rfhg_37338.1

Basic information about the TSS

---

TSS ID: rfhg_37338.1 Species: human Chr: chr2		Start: 201116805 End: 201116828 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3231324,EH38E2065829)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000441224.5:9 GeneID: 8837 HGNC/MGI_ID: HGNC:1876 UniProt_ID: C9J408 Nearer transcript ids and distances:

Gene_name: CFLAR Gene_symbol: CFLAR Gene_synonyms: CASH CLARP Casper FLAME FLIP I-FLICE MRIT c-FLIP cFLIP Gene_source: HGNC:1876

TATA-Box annotation

---

Distance to TSS:	652
Nearest PromoterID:	NR_147251
Entrez ID:	8837
Nearest Unigene:	Hs.390736
Nearest Refseq:	NM_003879
Nearest Ensembl:	ENSG00000003402
Gene Name:	CFLAR
Gene Alias:	CASH|CASP8AP1|CLARP|Casper|FLAME|FLAME-1|FLAME1|FLIP|I-FLICE|MRIT|c-FLIP|c-FLIPL|c-FLIPR|c-FLIPS|cFLIP
Gene Type:	protein-coding
CpG%:	0.086957
GC%:	0.708333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CFLAR p2@CFLAR p3@CFLAR p4@CFLAR p5@CFLAR p8@CFLAR p9@CFLAR p10@CFLAR
Sample		p1@CFLAR	p2@CFLAR	p3@CFLAR	p4@CFLAR	p5@CFLAR	p8@CFLAR	p9@CFLAR	p10@CFLAR
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.87	0.00	2.34	0.00	0.19	0.97	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.06	0.61	1.42	0.00	0.00	0.20	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.98	0.00	1.93	0.00	0.00	0.19	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.57	0.21	1.87	0.00	1.04	0.42	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.05	0.22	1.35	0.00	0.90	0.00	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.88	0.58	2.33	0.00	0.78	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.88	0.44	3.92	0.00	0.65	0.44	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.63	0.00	2.91	0.00	0.97	0.48	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.42	0.00	3.85	0.00	0.21	0.85	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	1.16	4.64	0.00	0.58	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.43	0.00	7.68	0.00	0.00	1.62	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	4.47	0.81	4.88	0.00	0.41	1.22	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.19	5.48	1.29	0.16	4.67	0.48	0.16	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.87	6.01	1.50	0.00	4.66	0.45	0.00	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.54	3.95	0.88	0.22	4.17	0.44	0.44	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.80	6.29	1.01	0.25	2.51	1.01	0.75	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.55	4.15	1.97	0.44	4.15	0.44	1.09	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.22	4.22	3.37	0.42	4.22	0.42	2.95	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	11.73	2.13	1.07	8.00	0.53	0.53	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.22	8.88	1.05	1.65	6.47	1.65	1.81	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.29	10.02	1.07	1.47	5.75	1.20	1.87	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.32	11.39	1.90	1.21	7.25	2.07	1.21	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.86	9.18	1.81	2.33	6.46	1.03	1.55	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.28	7.04	1.21	1.21	4.37	0.97	0.97	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.45	10.32	2.58	2.32	5.68	1.81	2.06	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	12.66	1.58	1.27	8.23	0.95	2.22	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	10.44	0.55	3.30	9.89	1.65	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.54	15.09	1.89	4.72	10.61	2.59	1.89	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.11	15.83	0.97	2.91	9.05	1.45	1.94	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	15.38	1.45	4.89	8.87	1.45	1.45	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	8.79	16.12	1.26	2.30	7.96	1.47	3.14	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.40	15.24	1.17	3.91	8.79	1.95	2.74	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.61	13.29	2.11	2.95	8.44	1.69	2.11	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.34	21.61	2.64	6.76	11.55	2.80	4.62	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.28	17.58	1.87	5.98	10.28	1.87	5.24	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.20	19.74	0.96	4.60	10.16	3.45	4.02	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.18	19.21	2.25	5.31	12.47	1.84	3.88	4.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.66	20.55	1.81	7.66	9.47	2.62	3.22	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.96	16.48	1.62	6.21	13.78	1.89	3.78	4.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.76	18.96	3.36	5.52	7.44	1.68	5.28	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	18.59	1.41	3.76	9.18	1.88	2.59	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.93	19.03	2.34	4.98	11.71	3.51	3.66	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.39	15.18	2.53	5.69	9.49	3.37	4.64	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.36	17.13	1.92	5.77	10.14	2.45	4.55	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.25	18.67	1.61	6.22	7.23	4.22	4.42	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.03	17.22	2.56	4.89	7.21	2.09	4.19	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.12	15.83	0.96	3.60	6.72	1.20	3.60	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.73	17.88	1.79	6.26	9.84	2.09	4.17	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.01	17.00	1.68	4.07	8.86	0.72	4.07	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.95	15.37	1.82	2.83	8.09	1.42	2.63	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.84	13.94	2.87	4.92	8.40	2.05	4.92	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.89	14.68	2.00	4.00	9.78	2.45	4.45	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	111.94	27.98	27.98	13.99	13.99	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.48	10.29	1.77	7.10	10.65	0.71	5.68	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.59	14.58	2.32	3.65	9.28	1.66	4.64	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	45.30	43.62	4.19	5.87	17.62	2.52	6.71	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	21.58	2.76	2.30	13.78	1.38	5.97	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.37	12.96	0.97	3.57	10.37	1.30	4.21	7.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.71	17.34	2.89	2.25	9.96	1.28	2.25	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.46	31.12	2.83	5.66	14.14	2.51	10.06	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	16.22	2.82	4.94	7.76	2.82	2.12	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	20.75	0.56	1.68	11.22	0.00	3.93	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	51.75	1.59	6.37	14.33	4.78	15.92	7.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.55	28.54	1.36	4.76	12.57	2.72	8.49	10.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	21.77	2.27	8.77	11.70	1.30	6.17	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.19	20.59	1.42	3.90	10.29	2.84	4.26	6.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	161.64	16.16	16.16	32.33	0.00	16.16	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	134.26	0.00	39.49	55.28	15.79	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	22.43	0.49	15.11	15.11	3.41	16.58	15.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	25.79	1.49	17.85	14.88	3.47	13.39	10.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.04	32.84	0.94	15.48	16.89	1.41	16.42	15.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.93	49.35	2.98	23.85	19.54	3.64	24.84	20.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.35	34.03	2.17	16.09	11.14	2.78	20.11	20.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.03	28.43	2.14	10.70	11.62	1.22	12.84	11.31
Adipocyte - breast, donor1	11376-118A8	25.02	0.95	8.55	0.00	1.90	0.16	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	24.55	1.76	6.26	0.16	0.64	0.00	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	33.08	3.18	9.67	0.13	1.91	0.38	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	20.18	1.49	8.22	0.75	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	23.78	2.68	6.36	0.00	2.01	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	13.40	1.28	4.47	0.00	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	0.00	4.40	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.65	2.26	3.61	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.81	1.22	2.95	0.00	0.70	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	29.14	4.69	5.08	0.20	4.50	0.39	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	30.63	4.38	2.57	0.51	4.89	1.03	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.84	3.35	6.41	0.28	0.84	0.56	1.12	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	32.33	2.94	8.23	0.00	2.35	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.24	2.90	9.09	0.00	0.88	0.16	0.24	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	30.34	5.81	7.42	0.00	2.58	0.65	0.97	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	28.79	1.07	4.80	0.00	0.53	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	32.27	1.67	8.35	0.00	0.56	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	36.18	0.83	13.72	0.00	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	25.87	3.77	6.28	0.50	2.01	1.00	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	30.76	1.64	8.18	0.00	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.79	0.91	10.35	0.00	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	5.97	6.85	1.55	0.22	5.75	2.43	0.22	2.87
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	5.02	0.72	0.00	2.87	2.87	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	2.40	1.20	0.00	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.03	0.72	7.74	0.00	1.08	3.78	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	5.02	0.00	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	13.15	1.03	6.37	0.00	0.62	2.05	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	10.87	0.80	0.69	0.00	0.11	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	12.49	0.73	0.24	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.73	4.49	1.80	7.64	3.15	0.90	1.80	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.63	3.91	1.74	4.78	2.60	0.00	2.60	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	0.00	2.14	0.00	2.14	8.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.46	5.98	2.39	6.88	2.69	0.30	1.49	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	3.79	1.26	5.06	1.26	1.26	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	3.30	1.32	6.60	3.30	1.32	2.64	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	2.60	2.27	4.87	1.95	0.65	0.97	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.48	6.31	0.97	3.40	3.88	1.94	0.97	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	2.38	3.56	5.94	1.78	0.59	1.78	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	4.14	2.26	4.52	1.88	1.13	1.51	3.01
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	3.63	4.35	5.08	1.45	0.00	2.18	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	0.00	0.00	2.51	5.02	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.29	2.14	3.13	2.97	3.13	0.99	2.14	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	4.09	6.82	8.19	6.82	0.00	1.36	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.20	2.87	2.87	4.22	1.66	0.75	2.26	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	2.14	1.61	5.36	1.61	0.54	2.68	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.49	1.51	2.08	3.40	0.94	0.57	1.51	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	1.07	2.14	4.28	1.34	1.60	2.41	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	1.95	3.90	5.85	0.98	0.00	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.95	2.49	1.16	5.64	1.66	0.66	1.16	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	4.80	1.20	3.60	3.60	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	7.08	0.00	3.54	3.54	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.86	2.40	2.57	3.95	2.23	0.17	1.20	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	4.19	0.00	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	3.40	3.40	2.43	1.94	0.97	0.97	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	4.17	2.28	3.42	3.42	0.38	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	2.42	0.00	3.63	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	3.99	2.85	2.28	1.14	0.00	1.14	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	2.99	2.78	1.50	1.92	1.07	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.81	2.06	1.29	2.58	0.26	1.29	1.81	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	1.41	1.41	2.82	5.16	0.47	0.47	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	1.93	3.22	2.57	0.96	0.32	0.96	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	3.57	2.14	4.99	2.14	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	4.68	1.75	1.75	3.51	0.00	0.58	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.63	2.71	4.22	3.31	2.41	0.60	1.81	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	2.38	3.56	5.94	1.19	3.56	1.19	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	3.56	3.56	6.61	4.58	1.53	2.54	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.48	4.08	2.04	6.88	1.78	0.51	2.80	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	2.54	1.91	5.72	1.91	1.27	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.36	6.90	3.88	5.18	2.59	0.86	2.59	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.43	4.23	2.96	8.04	2.33	0.64	1.69	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.99	2.61	2.03	5.80	1.45	0.29	1.45	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	3.78	2.83	7.56	1.89	0.00	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.49	3.56	2.37	6.44	1.86	0.00	2.20	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	4.63	2.32	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	2.11	6.34	2.11	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.72	3.86	2.36	10.94	3.22	0.86	0.86	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	1.80	5.41	9.63	1.80	1.80	1.80	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	5.10	4.37	8.02	5.10	1.46	3.64	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.71	4.60	1.84	10.80	2.30	0.92	2.76	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	0.00	5.10	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.97	4.07	4.32	16.53	2.80	1.27	3.81	2.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	3.92	3.10	11.35	2.89	0.21	1.65	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	2.14	1.53	7.34	2.45	0.31	0.92	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	4.78	1.43	13.86	1.43	0.00	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.64	2.66	3.33	7.10	2.22	0.67	2.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	4.58	3.05	9.15	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	2.22	2.22	4.43	1.11	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.71	2.91	2.91	6.62	1.32	1.06	2.38	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.81	3.63	3.27	9.45	1.82	1.09	2.18	0.73
Astrocyte - cerebellum, donor1	11500-119F6	7.12	0.49	3.68	0.00	0.61	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	3.77	0.00	1.88	0.00	0.34	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.24	0.00	0.63	0.00	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	6.97	0.70	9.76	0.00	0.35	0.35	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	6.79	0.81	6.31	0.32	0.97	0.00	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	8.50	1.49	8.20	0.15	0.45	0.30	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.33	15.37	0.69	5.05	8.37	4.93	5.85	7.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.01	11.78	0.50	5.89	7.52	4.64	5.26	7.14
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.01	14.11	0.68	3.07	5.23	4.21	6.26	8.53
Basophils, donor1	12241-129G9	58.58	19.88	13.60	0.78	13.60	4.71	0.26	0.00
Basophils, donor2	12242-129H1	102.47	29.95	21.65	1.44	31.39	7.22	1.08	0.72
Basophils, donor3	12243-129H2	34.10	11.02	12.49	0.73	8.53	3.82	1.03	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	9.92	0.00	1.94	0.00	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.46	2.29	0.00	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	0.63	3.14	0.00	0.00	0.00	0.63	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	5.41	0.21	3.54	0.42	0.21	0.00	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	13.36	0.69	6.22	0.00	0.00	0.00	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	15.12	0.00	2.16	0.00	0.00	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.89	1.24	0.31	0.00	1.55	1.24	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.66	3.49	0.23	0.70	2.56	1.63	0.70	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.30	5.76	1.28	0.00	6.72	3.20	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	10.34	0.00	0.00	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	68.75	18.03	25.36	23.67	19.16	7.89	5.64	0.00
CD14+ Monocytes, donor2	11305-117B9	96.33	47.51	34.15	33.04	22.27	10.39	5.20	0.19
CD14+ Monocytes, donor3	11381-118B4	101.65	52.91	41.93	44.35	27.00	10.32	3.95	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	45.00	25.47	19.81	0.28	7.93	4.25	1.13	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.91	16.30	21.61	0.38	14.03	4.17	1.52	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.75	19.72	22.03	0.33	7.23	4.27	1.31	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	81.24	13.01	9.25	1.45	6.65	6.79	13.44	5.49
CD14+ monocytes - mock treated, donor2	11873-125C1	53.71	11.47	9.35	1.51	6.64	3.62	16.90	9.05
CD14+ monocytes - mock treated, donor3	11883-125D2	78.41	17.06	11.84	3.08	9.71	6.16	15.16	3.08
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	70.64	24.11	10.88	30.80	11.55	5.19	25.61	8.70
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.89	23.74	11.32	23.46	11.87	6.90	28.71	13.80
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	77.35	38.92	15.87	71.90	21.82	8.93	45.37	30.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	66.18	17.23	8.81	46.01	9.59	4.90	26.04	11.94
CD14+ monocytes - treated with BCG, donor2	11870-125B7	52.35	19.05	12.29	31.51	9.61	4.81	21.90	10.15
CD14+ monocytes - treated with BCG, donor3	11880-125C8	88.14	37.87	18.06	80.31	20.89	8.92	52.23	18.50
CD14+ monocytes - treated with Candida, donor1	11868-125B5	81.94	38.87	14.98	201.58	20.37	11.47	38.40	10.54
CD14+ monocytes - treated with Candida, donor2	11878-125C6	76.04	44.88	24.82	224.94	20.07	7.92	45.41	12.67
CD14+ monocytes - treated with Candida, donor3	11888-125D7	95.40	43.26	16.64	276.23	23.30	6.66	38.83	21.08
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	79.73	20.68	10.11	8.33	12.64	9.22	24.25	8.33
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	53.48	18.96	11.97	6.39	11.57	6.39	30.53	14.57
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	83.90	43.72	15.41	30.61	19.36	13.53	46.43	20.82
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	85.34	34.09	15.33	240.68	14.87	6.63	48.96	14.18
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	76.91	38.68	15.16	168.75	22.17	14.70	53.16	20.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	74.63	42.77	14.84	282.83	17.89	5.24	44.52	20.08
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.94	11.30	11.84	8.61	6.72	5.11	10.76	6.72
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	63.33	16.05	10.99	10.12	6.63	5.23	20.94	13.96
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	71.54	18.94	17.67	13.05	6.31	7.15	18.10	7.15
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	68.34	26.09	10.66	311.76	13.04	4.96	45.74	10.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	43.68	25.36	5.28	308.94	8.10	2.47	36.64	14.09
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	53.09	39.49	11.85	532.17	21.50	10.53	39.05	13.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	73.93	11.33	10.81	8.72	8.54	3.31	12.21	7.67
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	60.95	21.19	10.04	13.01	8.18	4.09	20.44	12.64
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	96.57	34.70	17.03	30.61	17.46	5.60	39.23	24.14
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	59.79	22.93	13.10	298.52	13.92	6.14	38.08	13.92
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	61.19	32.22	14.60	378.30	19.93	8.58	49.37	15.76
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	66.12	46.40	14.85	658.39	33.64	13.69	64.96	17.86
CD14+CD16+ Monocytes, donor1	11789-124B7	46.21	14.82	13.08	0.22	11.12	5.45	2.83	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	39.27	20.33	14.09	1.39	13.63	6.24	3.70	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	47.87	19.93	15.60	1.08	15.16	5.63	1.30	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	99.51	10.28	19.15	0.00	10.90	6.85	1.25	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	83.83	8.73	19.73	0.52	8.91	4.19	1.22	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	122.63	16.05	27.20	0.22	11.59	8.92	0.89	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	50.52	28.32	14.03	0.77	22.71	6.12	3.57	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	47.87	31.18	12.08	0.22	15.15	4.39	1.76	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	56.43	24.84	14.32	0.21	19.58	4.84	3.16	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	24.39	0.00	8.13	10.16	6.10	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	45.42	16.95	2.03	0.68	12.88	7.46	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	49.71	21.75	3.11	0.00	12.43	2.07	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.31	15.46	2.13	4.80	12.26	7.46	0.53	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	50.93	12.87	1.61	0.54	15.01	6.43	0.00	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	51.24	17.55	0.70	0.70	20.36	4.91	0.00	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	41.57	20.39	2.35	0.00	18.82	3.14	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	25.05	2.64	0.00	25.05	3.95	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	85.48	14.79	3.29	0.00	9.86	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	46.43	15.96	1.45	2.18	8.71	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	62.60	18.17	5.05	2.02	8.58	6.56	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.50	5.25	3.23	0.00	5.25	2.42	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	3.60	0.80	0.00	3.60	2.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	35.14	9.04	2.01	1.00	10.04	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	56.18	18.54	5.06	32.02	19.10	3.93	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	17.28	6.39	1.50	0.00	5.64	2.63	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.48	7.22	2.93	0.00	8.12	2.93	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	168.53	20.00	3.21	0.71	20.35	3.57	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	175.75	20.21	2.45	1.22	11.63	1.84	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	95.16	22.87	0.91	0.91	22.57	3.35	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	57.94	43.39	1.02	2.81	51.30	6.89	1.02	9.19
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	54.80	40.20	0.90	2.02	39.30	4.72	1.57	14.15
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	56.34	37.37	2.01	3.74	37.66	4.60	2.30	9.49
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	131.80	16.59	0.95	0.00	27.97	0.95	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	155.92	24.58	2.11	0.70	37.93	4.92	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	164.81	9.89	0.00	0.00	26.37	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	37.72	36.42	0.87	6.94	39.02	5.35	3.47	14.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.13	36.27	0.34	7.96	30.67	3.56	0.34	7.12
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.85	39.17	1.13	7.74	34.66	5.16	0.81	10.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	112.07	44.83	0.90	0.90	52.90	5.38	0.45	3.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	107.26	48.91	1.40	2.10	51.01	6.99	0.00	4.54
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	127.15	52.36	1.32	0.44	56.32	4.84	0.88	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	51.86	21.08	3.79	0.42	24.03	4.22	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	27.84	18.28	0.83	0.62	15.79	2.08	0.21	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.38	14.37	0.67	0.00	15.04	2.34	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	151.74	8.43	0.82	0.00	16.59	1.09	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	171.50	14.47	1.07	0.00	23.05	2.68	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	138.08	5.38	1.79	0.00	8.97	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.71	40.42	0.74	1.67	34.12	6.12	0.93	8.72
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.11	36.39	0.43	0.65	33.58	5.63	0.65	6.50
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.04	41.82	0.63	1.05	41.19	7.36	0.63	7.15
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	124.88	58.65	2.02	0.51	66.23	5.06	1.01	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	110.05	54.16	2.60	0.43	58.49	8.67	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	142.95	64.50	0.87	0.44	58.40	8.72	0.00	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	113.82	55.43	1.98	1.48	70.27	9.90	0.49	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	92.32	57.24	2.77	0.00	74.78	7.39	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	83.75	82.35	2.79	1.40	85.15	6.98	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	114.93	53.72	4.43	0.55	53.45	5.82	0.55	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	102.33	59.63	3.19	0.74	60.61	6.63	0.25	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	127.82	52.36	3.08	1.54	60.06	6.16	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	112.09	74.13	3.94	0.36	66.61	13.25	0.72	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	94.18	74.79	0.00	1.38	65.09	6.92	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	105.42	38.96	5.89	0.33	32.41	2.95	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	110.38	37.54	6.76	0.38	25.90	4.51	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	142.15	20.45	4.54	0.50	15.91	1.77	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.72	8.49	0.46	1.61	11.47	1.15	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.43	9.83	0.96	1.20	9.11	2.88	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.67	7.93	0.82	2.74	10.12	4.10	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.41	15.01	0.30	3.30	16.51	5.40	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.76	13.20	0.96	2.16	9.36	4.56	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.69	8.87	0.91	2.73	17.96	2.50	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.91	12.82	1.09	1.52	13.69	1.52	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.00	6.58	0.53	1.05	14.48	5.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.97	9.62	1.41	2.58	14.07	3.52	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.87	11.77	0.30	2.11	10.87	4.83	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.88	10.75	0.87	1.45	11.91	4.07	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.66	13.06	0.80	1.07	13.32	6.39	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.00	18.82	3.06	2.19	22.76	4.38	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	17.76	3.64	2.73	19.13	5.92	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	20.14	2.24	4.48	20.14	3.73	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.92	12.61	0.00	2.16	9.72	3.60	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.92	12.37	0.58	4.03	16.11	2.88	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.25	7.78	0.71	1.65	13.67	6.60	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.73	10.46	1.58	1.90	17.11	4.44	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.30	10.46	0.62	1.23	13.53	4.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.62	11.54	0.64	1.28	17.31	3.53	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.56	14.92	0.38	1.15	16.45	4.21	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.34	11.82	0.00	1.97	12.61	2.36	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	9.08	1.51	1.51	12.86	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	29.71	3.21	2.41	27.30	3.21	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	28.68	4.90	2.10	25.88	13.29	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	5.01	28.05	1.00	3.01	28.05	8.01	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	25.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	7.41	0.99	0.00	0.00	1.98	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	6.00	1.68	1.47	0.32	1.58	0.53	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	14.56	0.00	4.85	0.35	1.04	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	14.22	0.00	5.33	0.00	0.36	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	19.11	0.68	2.39	0.00	0.80	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	14.32	0.00	2.69	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	21.84	1.21	5.26	0.00	0.81	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	12.85	1.03	4.93	0.00	1.72	0.69	0.46	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	10.47	1.28	2.78	0.00	1.07	0.21	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	9.65	1.50	1.95	0.44	1.42	0.27	0.18	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	35.30	16.60	14.21	1.10	7.89	4.49	1.56	2.93
Corneal Epithelial Cells, donor1	11526-119I5	7.25	0.00	4.17	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	12.51	0.00	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.95	0.26	3.32	0.00	0.00	0.00	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.37	8.09	1.49	20.80	9.08	5.78	2.15	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.25	11.35	1.26	22.08	10.72	6.94	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	17.25	0.00	20.70	10.35	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.36	6.91	1.19	22.57	6.26	3.67	1.40	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.05	5.12	4.10	4.10	5.47	14.01	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	45.05	14.36	9.14	2.61	5.22	24.81	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.10	3.39	2.42	3.87	4.84	10.16	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.67	13.17	2.67	8.67	5.00	7.84	11.01	19.18
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	6.45	2.35	6.45	2.35	2.93	2.35	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	3.39	11.03	1.70	5.09	3.11	5.37	8.77	11.03
Endothelial Cells - Aortic, donor3	11412-118E8	9.04	8.26	1.57	5.11	2.75	3.54	4.33	7.86
Endothelial Cells - Artery, donor1	11264-116G4	6.69	10.76	1.16	14.25	2.33	1.45	6.11	8.73
Endothelial Cells - Artery, donor2	11341-117F9	4.24	7.76	2.12	7.76	3.53	2.35	8.71	14.82
Endothelial Cells - Artery, donor3	11413-118E9	4.38	12.97	1.93	9.29	6.31	6.14	5.26	8.41
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.42	14.63	3.10	6.21	6.87	5.98	9.97	6.65
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.87	19.17	3.35	10.04	6.69	5.48	11.56	8.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.56	18.32	6.48	6.48	9.58	4.23	9.58	18.04
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	8.02	6.24	12.18	3.57	4.46	5.94	6.83
Endothelial Cells - Microvascular, donor2	11342-117G1	5.73	10.41	7.29	11.98	4.69	3.12	9.37	6.77
Endothelial Cells - Microvascular, donor3	11414-118F1	8.37	4.54	4.82	5.10	2.55	3.12	2.41	1.99
Endothelial Cells - Thoracic, donor1	11266-116G6	3.20	9.60	4.00	10.80	6.00	4.00	10.00	12.80
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	11.53	1.05	4.72	2.62	1.05	4.19	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	12.30	12.92	6.59	5.84	8.95	5.96	11.93	13.54
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.30	8.91	3.26	2.17	5.00	4.56	3.48	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	5.74	11.97	5.13	2.56	4.89	5.62	3.91	2.69
Endothelial Cells - Vein, donor1	11267-116G7	5.69	4.55	0.00	5.69	4.55	5.69	3.41	6.83
Endothelial Cells - Vein, donor2	11344-117G3	6.29	12.57	6.29	6.29	5.59	0.70	6.99	17.46
Endothelial Cells - Vein, donor3	11416-118F3	4.08	7.22	3.77	5.02	4.08	3.30	2.04	5.18
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	377.91	117.17	74.26	113.87	80.86	79.21	19.80	3.30
Eosinophils, donor3	12246-129H5	420.89	139.11	60.64	164.07	89.17	53.50	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.84	0.24	2.20	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.49	1.23	2.46	0.41	1.23	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.26	1.53	1.09	0.33	1.31	0.44	0.22	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.37	0.54	1.41	0.22	0.65	0.11	0.22	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.25	0.97	3.52	0.36	1.33	0.73	0.49	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	42.99	10.92	9.01	1.77	11.19	2.46	0.96	5.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.29	1.16	0.95	0.32	1.69	0.21	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	1.84	3.69	0.79	1.84	0.00	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.30	1.99	1.33	1.00	1.00	0.00	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	6.35	0.00	0.45	0.00	1.36	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	6.82	1.52	3.03	1.52	2.27	0.76	2.27	3.79
Fibroblast - Cardiac, donor3	11417-118F4	5.36	0.79	2.52	0.79	0.47	0.16	0.16	0.79
Fibroblast - Cardiac, donor4	11452-119A3	9.09	3.03	3.94	0.00	0.61	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	10.28	10.15	3.17	2.41	3.81	2.92	2.03	5.33
Fibroblast - Cardiac, donor6	11460-119B2	6.67	7.28	3.49	0.76	4.55	0.91	1.06	3.49
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.79	1.61	2.81	0.00	1.34	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	1.29	2.16	0.00	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	4.39	0.00	0.00	4.39	2.93	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	6.00	0.00	1.61	0.00	0.23	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.71	0.17	1.70	0.00	0.17	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	16.43	0.47	2.11	0.00	0.00	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.98	2.36	3.30	1.42	2.83	0.47	2.83	2.36
Fibroblast - Dermal, donor3	11418-118F5	16.68	0.60	2.78	0.12	1.81	0.12	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	6.90	0.11	5.43	0.00	0.57	0.11	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	8.02	0.17	2.62	0.00	0.35	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	9.10	0.16	3.74	0.00	0.49	0.00	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	14.99	0.62	5.41	0.00	1.25	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.29	1.31	5.24	0.00	0.26	0.26	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	10.67	0.40	1.98	0.00	0.26	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	21.66	1.55	3.38	0.00	1.35	0.19	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	40.52	0.00	10.39	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.25	0.53	3.52	0.00	0.53	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.53	0.31	4.52	0.16	0.94	0.16	0.16	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.50	0.95	4.73	0.14	0.54	0.14	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.00	1.06	4.94	0.71	1.06	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.50	1.32	3.95	0.00	0.29	0.15	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.23	1.77	4.09	0.14	0.55	0.27	0.00	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	13.38	0.88	4.50	0.11	0.55	0.11	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	45.05	1.03	4.55	0.15	1.32	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	9.52	1.36	1.36	0.00	4.08	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	0.00	2.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	12.24	0.21	1.90	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.83	2.50	0.00	0.00	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	0.00	0.00	4.20	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	3.36	0.00	0.00	3.64	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	11.37	1.62	1.62	0.00	0.81	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.06	0.19	3.49	0.00	0.78	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.92	0.30	3.49	0.00	0.30	0.15	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.85	1.84	4.59	0.00	0.92	0.61	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.74	2.29	3.82	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.42	1.62	4.86	0.00	0.81	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.30	1.04	3.48	0.12	0.35	0.12	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.31	3.87	2.21	1.33	2.21	1.22	1.11	3.43
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.71	4.47	3.25	0.00	2.44	1.63	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	0.00	2.67	0.00	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.33	0.40	1.19	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	27.39	2.58	16.47	1.98	0.99	0.40	0.60	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.80	0.89	10.66	0.18	1.07	0.00	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.17	0.99	4.34	0.39	2.37	0.00	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	2.71	8.42	0.60	0.90	0.00	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.04	1.08	5.18	0.32	0.76	0.00	0.22	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.96	0.76	17.72	0.51	2.53	0.00	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	14.77	0.82	8.04	0.00	0.82	0.49	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.44	1.60	7.62	0.60	1.40	0.20	0.40	1.00
Fibroblast - skin normal, donor2	11561-120D4	9.85	0.50	5.73	0.00	0.30	0.00	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	40.80	1.21	16.02	0.30	1.51	0.30	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.32	0.83	5.22	0.08	0.99	0.08	0.41	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	31.11	0.68	3.76	0.17	0.85	0.00	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	28.90	2.63	17.41	0.66	0.99	0.00	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.57	1.17	6.60	0.32	1.28	0.11	0.43	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	11.98	0.84	5.40	0.34	0.84	0.00	0.51	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.05	0.31	5.18	0.00	1.88	0.16	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	44.32	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	44.45	2.61	10.46	0.87	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.30	0.17	6.41	1.73	0.17	0.52	0.87	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.49	0.52	5.47	2.34	0.00	0.26	3.38	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.78	0.77	4.85	0.77	0.26	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.83	0.00	0.00	0.00	0.00	1.53	0.00	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.91	1.28	0.00	0.00	1.91	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.85	0.86	0.00	0.00	0.00	1.14	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.93	0.28	3.03	0.00	0.28	0.28	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.20	0.23	3.65	0.00	0.23	0.46	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1.78	0.20	0.99	0.00	0.59	0.79	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.70	0.53	2.38	0.00	0.00	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.94	0.00	2.94	0.00	0.33	1.63	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.86	0.88	0.00	0.00	1.33	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.35	0.57	1.55	0.00	0.14	1.27	0.00	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	8.37	0.25	3.20	0.00	0.49	0.99	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	0.27	0.81	0.00	0.27	0.54	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.58	2.11	4.71	0.00	1.12	0.74	0.12	4.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.51	1.25	2.77	0.00	0.42	0.83	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7.52	0.61	1.02	0.00	1.42	1.02	0.81	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	5.70	0.68	4.11	0.00	0.68	1.14	0.00	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.60	1.25	1.62	0.00	1.12	1.00	0.25	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.87	1.31	2.40	0.00	1.75	1.53	0.44	2.40
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.21	1.18	4.73	0.00	0.89	0.89	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.63	1.43	4.93	0.00	0.32	1.11	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	6.48	1.34	3.35	0.00	0.45	0.89	0.45	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	4.03	0.81	7.86	0.00	0.20	0.20	0.00	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	6.11	0.51	6.79	0.00	0.51	0.51	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	8.07	0.71	7.36	0.00	1.15	1.15	0.62	3.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.76	0.21	6.04	0.00	0.52	0.31	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.17	0.17	7.34	0.00	0.17	0.51	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.97	0.00	5.75	0.00	0.33	0.22	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.66	0.75	7.49	0.17	0.50	0.50	0.08	2.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.31	0.61	7.35	0.00	1.02	0.61	0.41	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	10.32	0.00	6.40	0.00	0.21	0.00	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.53	0.00	5.07	0.00	0.12	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.84	0.67	4.50	0.00	0.00	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.16	0.22	7.72	0.00	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	9.47	0.00	4.43	0.00	0.00	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.10	0.16	5.35	0.00	0.49	0.81	0.16	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.58	0.00	4.17	0.00	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	8.62	0.00	4.07	0.00	0.09	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	6.80	0.32	3.95	0.00	0.00	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	7.30	0.00	3.04	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	8.36	0.21	3.76	0.00	0.00	0.10	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.32	0.22	4.61	0.00	0.22	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	8.14	0.00	4.49	0.00	0.00	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.59	0.00	3.98	0.09	0.00	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	7.22	0.00	2.14	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.25	0.31	1.68	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.68	0.26	3.89	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	7.86	0.27	2.98	0.00	0.00	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.30	0.00	2.40	0.00	0.18	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.75	0.00	1.75	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	4.96	0.00	2.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.85	0.13	1.98	0.13	0.26	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.27	0.20	3.23	0.00	0.40	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	7.12	0.00	1.52	0.00	0.00	0.00	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.75	0.00	0.60	0.00	0.40	1.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.94	0.46	0.46	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.05	0.20	0.20	0.00	0.00	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	0.63	0.00	0.31	0.00	0.00	0.00	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.85	0.00	0.28	0.00	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	0.00	2.47	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	0.00	0.00	0.00	0.00	0.00	0.00	1.60	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	0.00	0.00	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.06	0.00	0.00	0.00	0.00	0.00	0.41	4.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1.63	0.00	0.33	0.00	0.00	0.00	1.31	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	2.52	0.00	0.00	0.00	0.00	0.00	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	0.00	0.00	0.00	0.00	0.00	0.00	0.64	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	0.68	0.00	0.34	0.00	0.00	0.00	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	0.00	0.00	0.00	0.00	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	0.00	0.00	0.00	0.00	0.00	0.00	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1.18	0.00	0.59	0.00	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	3.31	0.00	1.66	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	0.00	0.00	0.23	0.00	0.00	0.00	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	0.00	0.00	0.00	0.00	0.00	0.00	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	2.28	0.00	0.65	0.33	0.00	0.00	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	0.67	0.00	0.00	0.00	0.00	0.00	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	0.77	0.00	0.39	0.39	0.00	0.00	0.00	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	0.34	0.00	0.00	0.00	0.00	0.00	0.00	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	0.00	4.97	0.00	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	0.94	0.00	0.47	0.00	0.00	0.47	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	0.60	0.00	0.00	0.00	0.00	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1.02	0.00	1.02	0.00	0.00	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	0.80	0.00	1.20	0.00	0.00	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	0.00	0.00	0.00	0.00	0.00	0.00	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2.36	0.00	2.36	0.00	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.33	0.00	0.58	0.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	0.44	0.00	0.00	0.44	0.00	0.00	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.85	0.00	0.00	0.00	0.00	0.00	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1.79	0.00	1.19	0.00	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	0.00	0.00	0.49	0.00	0.00	0.00	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	29.67	5.71	13.70	0.00	3.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	0.83	4.16	0.00	1.66	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	0.00	4.50	0.00	4.50	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.75	8.25	7.29	0.32	3.81	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	29.24	2.09	2.09	0.00	2.51	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.02	1.28	6.50	0.00	0.93	0.58	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.50	0.68	4.90	0.00	0.68	0.17	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.69	2.05	6.14	0.00	0.46	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.65	0.98	4.92	0.11	0.98	0.87	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.11	1.50	5.37	0.00	0.64	1.50	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.49	1.08	5.17	0.00	0.22	0.86	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.71	0.75	4.48	0.12	0.25	0.50	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.26	1.03	3.43	0.00	0.51	0.51	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	0.96	4.81	0.00	0.64	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	11.75	2.24	1.12	3.92	2.80	1.12	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	2.16	1.30	0.00	3.03	0.87	0.43	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	10.58	0.00	7.93	2.64	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.41	0.35	1.41	0.00	1.41	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	0.73	1.45	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.55	2.97	0.52	0.35	1.57	0.87	0.70	1.22
Hepatocyte, donor1	11523-119I2	23.00	1.21	27.84	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	36.63	3.23	18.31	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	25.16	5.52	25.16	0.00	1.23	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	0.65	0.00	0.00	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	9.61	1.92	17.83	0.17	2.62	3.85	1.05	2.97
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.63	1.65	0.96	0.27	1.65	0.41	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	25.47	0.00	0.00	9.55	12.74	0.00	15.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	13.35	0.00	6.68	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	27.08	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	9.69	0.00	0.00	18.00	9.69	0.00	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	15.02	2.50	0.00	2.50	5.01	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	25.63	2.56	0.00	10.25	7.69	0.00	23.07
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	9.14	0.00	0.00	0.00	4.57	0.00	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	17.87	0.00	0.00	4.87	12.99	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	11.67	0.00	0.00	6.67	3.33	0.00	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	7.26	0.00	0.00	7.26	10.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	19.85	1.32	0.00	11.91	11.91	0.00	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	4.43	0.00	0.00	4.43	4.43	0.00	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	20.95	0.00	0.00	10.48	0.00	0.00	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.63	11.97	1.89	0.00	6.30	7.56	0.00	3.78
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	13.92	1.55	0.00	3.09	3.09	0.00	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	9.69	1.94	0.00	8.40	7.75	0.00	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	14.49	3.22	0.00	4.83	1.61	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	23.90	0.00	0.00	0.00	11.95	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	18.74	0.81	0.00	10.59	7.33	0.00	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	8.82	2.52	0.00	5.04	6.30	0.84	10.08
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	14.37	0.00	0.00	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	6.43	0.00	0.00	9.64	6.43	0.80	6.43
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	12.00	0.00	0.00	4.62	3.69	0.92	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.47	8.50	0.47	0.00	4.25	3.78	0.94	3.78
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	4.53	1.81	0.00	5.44	1.81	0.91	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	4.30	2.15	0.00	4.30	2.15	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	10.16	0.00	0.00	3.81	5.08	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.28	8.29	1.91	0.00	5.74	4.46	0.00	5.74
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	16.40	3.65	0.00	7.29	0.00	0.00	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	15.00	0.71	0.00	3.57	7.14	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	13.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	20.85	0.00	41.70
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.31	5.25	1.54	0.00	3.40	4.32	0.00	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	21.07	0.00	0.00	5.27	5.27	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	6.29	0.00	12.57	15.72	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	16.69	1.39	0.00	6.26	10.43	0.70	6.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	13.28	4.43	0.00	11.07	15.49	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	16.21	0.00	0.00	6.48	25.94	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	14.82	3.49	0.00	16.57	15.69	0.87	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	6.75	2.25	0.00	9.00	20.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	34.85	6.97	0.00	0.00	13.94	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	20.27	6.40	0.00	10.67	21.34	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	20.78	2.77	0.00	9.70	11.08	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	17.10	0.00	0.00	8.55	5.70	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	22.09	1.84	0.00	8.28	9.20	1.84	8.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	0.00	0.00	6.05	18.15	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	18.63	0.00	0.00	0.00	12.42	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	13.75	3.17	0.00	9.52	21.15	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	13.14	0.08	3.59	0.00	0.08	0.08	0.33	0.49
Keratinocyte - epidermal, donor2	11349-117G8	10.54	0.00	1.17	0.00	0.59	0.00	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	13.44	0.09	0.95	0.09	0.28	0.00	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	17.94	0.11	3.41	0.23	0.11	0.00	0.34	0.00
Keratocytes, donor1	11527-119I6	3.44	0.00	1.72	0.00	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	8.50	0.20	0.99	0.00	0.40	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	0.00	19.78	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2.16	4.31	3.24	0.00	1.08	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	6.34	1.15	4.04	0.00	0.81	0.58	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	5.35	1.72	2.42	0.20	2.62	0.40	0.20	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.30	7.35	7.00	32.02	4.27	3.79	10.91	7.94
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.35	4.74	4.19	13.40	2.79	3.35	3.91	5.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.21	6.93	8.66	18.57	2.99	4.09	7.24	5.19
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	9.14	4.84	17.74	3.23	2.15	4.84	5.91
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.77	5.04	1.89	12.61	4.10	1.89	6.62	2.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.23	6.25	5.18	12.51	2.70	2.26	6.04	2.80
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.42	7.80	5.75	21.34	4.10	3.69	6.57	2.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.15	3.29	3.03	13.40	1.01	2.02	2.78	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.39	5.35	7.32	10.70	2.82	3.80	5.77	2.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	3.96	4.35	17.40	3.16	3.56	8.70	5.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.35	2.33	3.88	15.90	1.36	1.94	5.04	4.46
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.44	2.96	4.81	13.15	3.33	2.04	3.89	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	6.27	5.23	18.81	1.74	1.74	4.18	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.12	6.68	2.39	15.74	3.10	3.10	4.53	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.77	6.04	5.49	14.97	3.43	2.06	5.08	3.02
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.78	2.77	2.77	24.64	2.46	2.77	6.47	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	2.81	4.99	16.83	1.56	2.81	3.12	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.36	5.31	5.86	13.36	3.11	4.21	3.66	3.11
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	8.89	4.61	23.70	1.32	2.96	5.59	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.18	2.93	4.69	12.89	3.22	2.93	3.51	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.43	3.24	6.22	9.71	3.73	2.24	2.74	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.70	6.79	5.82	21.34	1.94	0.48	3.88	6.30
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.27	4.31	4.31	12.93	1.62	3.50	4.58	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.80	6.21	6.36	13.02	3.63	2.88	4.54	3.94
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	3.11	4.15	17.63	1.04	0.52	7.78	6.22
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.66	3.14	3.77	15.70	2.72	2.30	2.72	4.19
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.09	5.11	5.41	13.53	2.26	1.80	4.96	2.86
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	4.13	4.13	15.82	2.06	4.13	4.82	5.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.98	4.52	3.57	17.50	2.07	3.01	5.46	3.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	13.36	6.04	4.24	12.51	4.24	2.76	5.41	2.12
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	7.75	1.94	18.90	3.39	2.42	7.27	5.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.22	4.30	6.62	19.19	2.65	1.98	3.31	4.30
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.64	7.68	5.33	13.75	3.84	2.60	2.97	4.21
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.47	6.29	4.44	19.25	3.70	1.85	5.92	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.38	4.20	2.22	15.32	2.47	2.96	3.46	4.45
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.00	4.81	3.44	9.49	3.16	2.61	3.02	2.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.37	7.08	4.18	16.40	5.79	3.54	5.79	5.15
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.96	5.78	4.26	21.91	3.65	2.74	3.65	4.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.02	6.44	8.26	16.10	3.50	3.64	7.42	3.22
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	5.69	4.62	19.91	2.84	1.42	6.04	3.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.57	1.94	4.36	8.24	3.88	1.94	2.91	3.39
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.32	4.51	5.14	11.51	2.80	2.02	2.80	3.89
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.53	7.52	6.45	17.55	2.86	4.30	4.66	5.01
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.01	3.59	7.51	16.99	2.29	3.59	3.27	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.60	4.47	3.53	10.12	3.53	1.88	3.30	3.06
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.71	7.43	7.43	24.38	5.45	4.08	8.91	6.81
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.76	3.33	2.56	9.99	1.79	2.56	3.59	3.84
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	5.67	9.25	12.83	1.79	3.88	4.18	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	0.00	4.53	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	0.00	3.84	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	0.74	4.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.16	0.00	5.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	0.00	7.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	0.00	3.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	0.00	3.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	4.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.70	0.00	4.30	0.00	0.23	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.25	0.00	4.36	0.00	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	0.00	2.25	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.58	0.14	5.15	0.00	0.14	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	0.00	4.62	0.00	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.47	0.35	5.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	0.00	2.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	0.00	3.06	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	0.00	4.54	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.01	0.19	4.16	0.00	0.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.02	0.00	4.29	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	0.00	4.08	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.87	0.00	5.21	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.17	0.00	3.64	0.00	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	0.00	5.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.93	0.00	4.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.66	0.00	3.59	0.00	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	0.00	2.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	0.00	2.83	0.00	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	0.00	6.27	0.00	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	1.15	3.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.73	0.77	7.68	0.00	0.00	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	0.57	6.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	0.00	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	0.45	1.81	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	0.00	7.18	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.19	0.00	4.48	0.00	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.61	0.00	4.09	0.00	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.54	0.00	3.88	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	0.00	5.99	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.99	0.33	5.00	0.00	0.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.10	0.00	2.41	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	0.71	4.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.40	0.00	4.81	0.00	0.00	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	0.00	6.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	0.00	4.04	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	0.00	4.07	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	0.00	6.98	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	0.00	3.17	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.41	0.00	3.20	0.00	0.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	0.00	2.91	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	0.77	5.37	0.00	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	16.28	0.00	2.96	0.00	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	0.94	4.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	18.60	0.00	8.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.83	0.00	8.11	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	6.88	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	0.00	3.12	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	23.46	1.17	5.47	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	0.00	3.96	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	0.52	2.59	0.00	0.00	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.38	0.00	4.81	0.00	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.57	0.00	6.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	0.44	3.97	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.90	1.16	5.40	0.00	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.22	0.00	6.58	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.34	0.00	3.84	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.27	0.00	4.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	0.00	3.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.29	0.00	2.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	0.00	4.18	0.00	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	0.00	3.10	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.12	0.00	1.81	0.00	1.21	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.70	0.00	4.12	0.00	0.00	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.39	0.00	4.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	0.00	3.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.91	0.00	4.11	0.00	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	0.71	4.95	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	20.43	0.00	3.40	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.48	0.00	4.16	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	0.00	6.26	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.78	0.42	3.34	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.05	0.46	5.11	0.00	0.00	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	0.00	5.35	0.00	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.78	0.00	2.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.42	0.00	4.04	0.00	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	0.00	3.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	0.89	4.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	0.00	4.56	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	0.00	3.07	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	1.09	1.64	0.00	0.00	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.82	0.45	3.12	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.64	0.26	5.72	0.00	0.52	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	0.00	3.98	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	0.00	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.49	14.13	8.89	0.00	7.07	4.56	2.73	1.82
Macrophage - monocyte derived, donor2	11313-117C8	21.47	11.93	4.40	2.39	8.26	2.02	6.61	1.10
Macrophage - monocyte derived, donor3	11389-118C3	25.82	11.27	6.55	0.13	5.37	2.36	2.88	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	1.06	4.25	1.59	0.53	0.00	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	24.88	0.48	11.41	2.06	0.16	0.32	1.27	1.43
Mallassez-derived cells, donor3	11930-125I4	17.10	0.56	6.95	5.42	0.56	0.42	4.31	1.39
Mammary Epithelial Cell, donor1	11273-116H4	16.84	0.30	3.89	0.00	0.20	0.30	0.00	0.30
Mammary Epithelial Cell, donor2	11350-117G9	13.90	0.58	8.11	0.00	0.00	0.00	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	6.98	0.25	1.75	0.00	0.50	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	23.05	16.27	0.00	12.88	17.63	2.71	7.46	2.71
Mast cell, donor1	11563-120D6	12.33	9.62	1.51	0.00	7.68	1.30	0.00	0.32
Mast cell, donor2	11565-120D8	45.47	24.37	13.08	1.49	13.97	2.97	0.00	0.00
Mast cell, donor3	11566-120D9	43.90	49.75	9.00	0.23	26.11	6.98	0.23	0.90
Mast cell, donor4	11567-120E1	37.41	14.71	10.81	0.53	10.81	2.84	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	17.63	7.10	1.33	0.89	8.87	1.11	0.78	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	21.01	8.76	0.00	1.17	9.92	2.92	0.58	2.33
Mast cell, expanded, donor5	11939-126A4	20.99	5.74	1.84	0.11	6.31	1.03	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	15.57	5.02	1.67	0.00	6.69	0.84	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	8.06	2.19	6.96	1.29	1.99	1.79	0.70	0.40
Melanocyte - dark, donor2	11582-120F7	10.38	1.38	3.11	0.00	1.04	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	9.63	0.07	0.65	0.00	0.07	0.07	0.00	0.00
Melanocyte - light, donor1	11274-116H5	8.93	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	15.70	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.00	1.73	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.56	0.10	1.04	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	6.99	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	12.32	0.00	1.07	0.00	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	6.95	0.62	5.71	0.00	0.87	0.12	0.25	0.12
Meningeal Cells, donor2	11573-120E7	5.72	6.16	1.76	0.00	2.20	3.08	0.00	0.88
Meningeal Cells, donor3	11654-122E7	8.97	0.49	3.83	0.49	0.33	0.33	0.24	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.84	0.86	2.85	0.86	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.97	0.91	0.81	0.40	1.91	0.00	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	2.62	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	6.46	2.87	2.15	1.44	1.44	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.32	1.27	4.87	0.00	1.48	0.00	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	0.50	4.02	0.00	1.51	0.00	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.49	0.00	1.76	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	0.00	1.46	0.00	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.52	0.20	0.82	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.99	0.69	1.39	0.14	0.28	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.43	1.86	0.37	0.00	2.60	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.95	1.32	2.11	0.13	2.89	0.39	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.17	2.08	1.48	0.00	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	0.00	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	11.70	0.71	4.96	0.71	0.71	0.00	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.51	2.50	1.88	0.00	3.44	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	4.35	0.00	0.73	0.00	1.45	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	11.14	5.83	1.33	0.53	3.45	0.27	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	9.51	5.51	1.00	1.00	3.00	2.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	10.26	7.66	0.79	0.43	4.99	0.79	0.22	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	12.15	5.40	1.35	6.75	2.70	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.40	10.34	4.43	0.49	7.39	2.22	3.69	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.20	5.89	4.42	0.00	5.30	3.24	2.94	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	6.91	6.91	0.00	3.46	13.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	14.26	4.96	3.10	4.96	3.41	3.72	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.03	4.98	1.87	2.28	3.94	2.28	3.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	16.21	2.32	6.95	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	23.77	15.27	5.01	12.76	5.76	1.75	3.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.34	9.78	3.26	6.05	6.05	2.33	1.86	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.29	10.57	5.49	25.81	7.11	2.24	4.06	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	7.13	4.36	10.30	6.73	5.15	3.17	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	11.50	6.19	37.17	4.42	1.77	9.73	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.16	8.36	5.70	27.74	6.46	3.42	4.18	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	13.16	1.32	6.58	3.95	6.58	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.55	9.97	3.18	78.52	2.55	3.18	3.82	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	5.52	3.68	8.29	4.60	4.60	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.11	9.54	1.49	71.24	6.86	1.79	3.87	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	18.44	1.68	3.35	5.03	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	9.28	3.51	135.99	4.77	3.26	7.53	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.74	7.84	3.09	38.74	8.08	3.33	4.28	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	8.29	6.63	36.49	12.16	2.76	1.66	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.41	11.51	2.99	166.01	7.37	1.84	8.06	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.09	13.46	4.21	46.27	11.99	5.26	3.79	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.06	11.41	4.48	137.18	7.95	4.48	5.50	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.17	9.44	3.86	114.13	6.01	1.07	6.65	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.01	13.34	4.89	42.46	11.78	5.78	4.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	10.32	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.71	11.83	3.94	119.15	7.23	2.41	3.50	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	11.66	4.06	22.81	9.13	3.55	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97	3.31	19.88	8.28	6.63	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.85	10.33	4.89	122.03	6.52	2.17	4.62	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.70	17.35	5.29	44.41	10.88	4.12	3.82	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	13.08	4.36	11.99	7.63	9.81	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	26.91	15.86	6.25	90.34	9.13	0.48	5.29	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	27.62	13.21	10.41	59.63	16.41	3.60	8.81	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	10.97	5.48	19.20	2.74	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	13.52	7.51	94.11	6.51	3.50	5.01	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	26.95	26.95	26.95	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	4.08	18.35	4.08	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	30.65	22.77	5.69	64.37	13.14	3.94	6.57	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	12.14	5.52	11.04	5.52	5.52	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	25.62	8.97	14.09	7.68	2.56	2.56	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	29.01	27.27	8.43	76.11	8.43	2.98	7.69	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	10.44	4.87	13.92	8.35	5.57	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	17.68	11.05	6.63	15.47	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	36.24	20.51	8.21	41.37	10.94	3.76	12.65	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.57	13.57	7.44	13.13	13.13	4.81	5.25	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	28.05	7.81	9.23	8.88	6.04	7.10	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.67	24.13	7.57	34.79	15.43	5.05	13.75	2.81
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.20	15.79	6.23	19.95	7.07	4.99	11.64	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	19.81	6.41	7.58	8.16	2.91	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.34	18.10	5.73	20.21	10.56	5.73	9.05	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	17.53	3.34	17.53	9.18	4.59	13.36	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	14.44	7.22	14.44	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	16.62	6.46	17.55	7.39	6.46	11.08	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	18.21	5.69	13.09	7.40	1.71	11.38	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.61	26.67	4.97	11.05	8.57	4.15	7.88	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.39	20.21	5.18	18.66	11.40	3.11	13.99	4.15
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.59	23.59	3.86	13.73	10.30	4.29	9.87	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	10.80	6.35	5.72	3.81	5.08	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.22	18.42	4.00	12.54	7.21	2.94	9.34	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	41.61	22.15	7.18	11.08	8.08	4.79	13.17	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.37	22.74	6.36	5.79	7.06	3.11	6.36	1.70
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.26	27.71	6.69	13.38	11.78	2.23	18.79	3.82
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.65	23.88	4.20	19.24	11.28	4.20	20.57	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.55	19.72	3.79	7.20	8.34	3.41	4.55	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	30.68	19.60	8.81	16.48	8.24	2.84	16.76	4.55
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	28.27	28.76	5.41	22.12	11.80	3.69	18.44	3.44
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	15.64	10.43	2.61	4.56	1.30	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	35.58	16.47	7.06	11.17	5.00	2.65	9.70	2.65
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	40.94	18.45	5.77	17.59	12.11	3.17	12.97	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.15	11.95	8.66	8.66	4.95	3.71	8.66	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	39.01	11.02	9.53	3.28	7.44	3.57	5.96	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	7.53	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	10.69	1.78	0.00	5.35	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.36	9.86	5.59	0.00	3.94	2.96	1.31	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	12.62	5.26	1.05	6.31	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.99	8.50	8.50	0.00	5.54	3.36	4.94	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	13.04	5.59	0.00	7.45	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.15	4.13	6.01	0.00	4.13	3.76	1.88	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.84	6.39	5.06	0.53	4.53	1.86	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.66	10.07	6.56	0.45	5.09	2.38	3.51	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	5.16	5.89	2.95	2.95	1.47	4.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	8.43	6.23	0.73	3.30	2.56	2.20	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	4.67	7.78	1.56	3.11	0.00	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.96	9.09	2.67	6.95	2.14	1.60	3.21	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	7.73	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	10.10	3.03	11.11	3.03	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	7.59	1.69	5.90	2.95	0.42	2.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	17.71	13.62	12.26	17.71	1.36	12.26	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.81	10.81	5.09	12.72	6.36	1.27	20.98	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	21.06	4.05	21.06	4.86	4.05	12.15	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	13.59	1.51	6.04	12.08	0.00	10.57	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	102.78	22.84	34.26	68.52	11.42	85.65	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	65.25	26.10	45.67	75.04	22.84	159.86	42.41
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	52.28	9.50	14.26	9.50	4.75	52.28	23.76
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	0.00	50.20	25.10	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.26	2.15	8.40	1.29	1.29	0.00	0.86	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	1.05	5.23	0.00	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	0.00	2.67	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.92	0.00	2.09	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.55	0.38	3.99	0.19	0.38	0.00	0.00	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	0.00	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	0.00	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	0.84	1.26	0.00	1.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.04	0.70	2.79	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.57	0.54	1.35	0.00	0.27	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.15	0.21	2.52	0.00	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.43	0.00	1.49	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.70	1.62	0.27	0.00	2.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	1.36	1.81	0.23	1.13	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.86	0.82	1.80	0.00	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.04	1.64	2.19	0.00	0.36	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	0.00	4.24	0.53	0.53	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	1.20	1.80	0.00	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.96	4.59	3.61	0.00	1.97	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	1.63	1.79	0.33	2.11	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.93	0.88	1.76	0.18	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	0.70	2.81	0.00	2.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	1.38	1.38	0.00	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.21	0.96	1.29	0.32	0.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	31.73	2.07	2.76	0.69	1.03	0.00	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	7.59	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.47	0.67	2.01	0.22	1.34	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	1.27	1.69	0.00	0.85	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.77	0.71	1.90	0.47	0.71	0.24	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	0.86	4.29	0.00	0.86	0.00	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	9.03	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.33	1.33	2.67	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	0.00	5.86	0.00	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	1.19	2.78	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	0.93	6.50	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	0.76	2.65	0.00	1.51	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	0.33	2.61	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.92	0.87	0.44	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	1.81	2.26	0.00	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	0.66	3.32	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	1.49	1.49	0.50	1.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	0.38	1.91	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.96	0.60	4.23	0.00	0.30	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.59	0.88	5.53	0.22	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	1.36	5.42	0.00	2.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	1.83	4.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	0.94	2.20	0.31	0.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	2.72	0.91	2.72	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	1.58	3.96	0.00	1.58	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	1.13	3.40	0.00	2.27	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	0.00	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.17	1.12	5.09	0.00	0.87	0.25	1.12	1.49
Myoblast, donor2	11322-117D8	21.48	1.73	5.37	0.19	0.77	0.00	0.00	0.58
Myoblast, donor3	11398-118D3	7.74	1.35	6.56	0.00	0.34	0.34	0.17	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	4.52	23.06	1.75	0.00	16.49	2.77	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	88.87	43.67	10.15	1.23	35.67	6.15	0.00	0.92
Natural Killer Cells, donor2	11311-117C6	114.89	40.11	5.43	2.11	22.32	6.03	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	118.90	40.12	9.94	2.94	28.16	4.05	0.18	0.37
Neural stem cells, donor1	11275-116H6	13.07	0.00	7.62	0.00	0.00	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	23.11	0.00	5.78	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	11.38	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	9.91	0.00	2.42	0.00	0.00	0.00	0.22	0.00
Neurons, donor3	11655-122E8	16.44	0.00	5.76	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	401.83	132.70	82.59	47.33	93.73	84.45	13.92	4.64
Neutrophils, donor2	11314-117C9	336.27	57.98	20.29	34.79	37.69	63.78	11.60	8.70
Neutrophils, donor3	11390-118C4	674.37	163.71	131.33	61.70	89.79	106.90	18.33	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	20.30	0.59	1.42	0.00	0.83	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	8.14	0.00	0.33	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.02	0.60	0.60	0.00	0.40	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.77	0.41	4.40	0.69	0.96	0.00	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	13.03	1.30	5.50	0.43	0.87	0.29	0.58	1.01
Olfactory epithelial cells, donor3	11935-125I9	13.39	0.79	3.97	0.34	0.79	0.00	0.34	0.23
Olfactory epithelial cells, donor4	11936-126A1	14.12	2.92	2.92	0.78	3.31	0.00	0.29	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	12.04	15.65	9.03	0.00	12.64	2.41	1.81	5.42
Osteoblast - differentiated, donor1	11276-116H7	10.85	0.64	2.77	0.21	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	1.14	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	0.00	0.62	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	6.25	0.98	1.37	0.20	0.78	0.00	0.20	0.20
Osteoblast, donor2	11354-117H4	6.32	1.40	0.00	0.00	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	12.44	0.89	1.96	0.36	0.71	0.53	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	15.84	1.18	3.12	0.00	1.01	0.00	0.08	0.25
Pericytes, donor1	11491-119E6	3.45	0.22	4.67	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	4.75	0.00	4.07	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	5.49	4.27	0.41	0.00	1.63	0.41	0.20	0.81
Perineurial Cells, donor1	11499-119F5	9.61	2.49	5.43	0.11	1.92	0.11	0.11	0.11
Perineurial Cells, donor2	11579-120F4	7.54	2.85	2.21	0.18	1.20	0.55	0.00	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	80.96	22.31	16.26	0.96	18.17	6.06	0.64	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	77.13	23.75	10.77	5.88	10.28	5.88	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	64.71	22.00	9.06	17.08	17.47	4.14	2.20	0.52
Placental Epithelial Cells, donor1	11278-116H9	7.89	0.72	2.87	0.24	1.20	4.30	0.24	1.20
Placental Epithelial Cells, donor2	11355-117H5	12.20	0.00	5.54	0.00	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.60	0.39	1.18	0.20	0.59	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	0.00	2.22	0.00	0.32	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	13.69	0.38	5.63	0.00	0.19	0.00	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.84	0.78	10.96	0.13	0.78	0.00	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	11.03	0.90	4.50	0.00	0.45	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	16.41	0.96	4.26	0.00	0.64	0.11	0.00	0.32
Preadipocyte - omental, donor2	11329-117E6	19.64	0.87	7.42	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	9.74	0.86	3.01	0.00	0.29	0.00	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	10.83	2.95	4.92	0.00	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	3.99	0.92	0.61	2.76	1.54	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	10.62	1.24	1.06	0.18	1.24	0.18	0.35	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	10.05	2.04	1.36	0.17	1.36	0.00	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	8.57	0.75	1.40	0.00	0.37	0.09	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	14.73	1.84	2.30	0.46	1.38	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	6.48	0.84	1.04	0.31	1.04	0.21	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	6.79	1.21	10.26	0.00	1.21	3.02	0.00	3.32
Prostate Epithelial Cells, donor2	11331-117E8	8.12	0.27	3.52	0.27	0.14	0.27	0.41	1.35
Prostate Epithelial Cells, donor3	11404-118D9	16.29	0.24	1.90	0.00	0.31	0.80	0.43	1.04
Prostate Stromal Cells, donor1	11254-116F3	10.93	1.94	1.59	0.11	2.39	1.03	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	12.91	2.69	1.08	0.18	3.77	0.90	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	19.92	2.19	1.46	0.00	1.56	0.63	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.57	5.47	5.11	0.36	1.46	2.55	1.09	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.55	7.28	6.38	1.46	4.71	3.40	1.32	3.26
Renal Epithelial Cells, donor1	11517-119H5	3.04	3.04	3.04	0.00	2.54	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	2.85	3.56	0.71	2.85	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	13.66	9.95	8.89	2.22	5.72	4.23	2.01	2.86
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	6.13	2.04	0.00	2.04	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.99	8.36	1.21	3.50	4.18	0.94	3.50	7.68
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.55	4.44	4.22	1.33	2.66	1.33	1.33	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	4.66	2.66	0.00	0.67	0.67	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	6.82	3.96	1.54	0.00	3.08	0.88	0.00	0.66
Renal Mesangial Cells, donor2	11598-120H5	10.03	1.25	3.13	0.00	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.99	1.66	2.77	0.00	1.39	1.39	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.54	11.81	6.17	1.07	7.78	6.98	1.88	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	3.80	5.90	0.42	5.48	2.95	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.14	5.01	4.05	0.19	4.44	2.89	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.41	1.81	2.59	0.00	1.04	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.26	2.56	0.85	0.00	1.99	0.00	0.00	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	0.00	1.03	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.77	1.25	2.51	0.00	1.76	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	38.09	24.46	24.72	0.94	11.23	4.68	2.00	9.35
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	0.00	7.15	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.01	0.00	12.66	0.00	1.10	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	9.86	1.16	11.60	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.41	0.26	5.85	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	9.24	0.30	4.77	0.00	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	11.15	0.22	8.25	0.00	0.33	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.78	1.12	5.58	0.00	0.37	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.74	0.23	4.31	0.00	0.00	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.09	0.46	5.55	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.89	0.41	3.29	0.00	0.41	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.89	0.15	4.08	0.00	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	9.68	0.90	4.84	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.17	0.00	3.87	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.48	0.00	2.90	0.00	0.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.29	0.00	6.20	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.75	0.00	2.68	0.00	0.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	9.22	0.09	4.56	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	13.34	0.38	8.46	0.00	0.00	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	8.36	0.66	4.11	0.00	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.44	0.39	4.77	0.00	0.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.69	0.19	7.26	0.00	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.94	0.21	4.49	0.00	0.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.41	0.56	4.77	0.00	0.00	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.03	0.17	8.54	0.00	0.00	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.93	0.36	4.74	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.87	0.12	5.03	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	10.21	0.27	6.58	0.00	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	15.10	0.24	2.59	0.00	0.71	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.33	0.20	3.37	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.26	0.23	8.65	0.00	0.47	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	0.21	4.35	0.00	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.95	0.00	6.64	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	10.03	0.21	3.76	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.84	0.13	5.11	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.03	0.51	4.26	0.00	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	7.71	0.39	6.36	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	9.97	0.34	3.27	0.00	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5.76	0.27	4.66	0.00	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.67	0.33	5.91	0.00	0.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	7.67	0.00	2.73	0.00	0.00	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.25	0.44	5.62	0.00	0.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.33	1.33	5.60	0.00	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.05	0.14	4.56	0.00	0.28	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	7.86	0.95	5.95	0.00	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	12.50	0.20	8.67	0.00	1.01	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.85	0.47	6.40	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.58	1.40	8.04	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	0.00	8.76	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.79	0.37	6.73	0.00	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.20	0.58	25.33	0.00	1.16	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.90	0.61	9.73	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.66	0.90	7.23	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.44	0.23	7.24	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.58	0.30	8.69	0.00	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	15.70	0.12	9.92	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.31	0.00	10.03	0.00	0.21	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	0.60	10.82	0.00	1.80	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	2.82	0.94	1.13	0.00	0.75	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	3.40	0.00	6.80	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	5.48	0.00	1.75	0.00	0.44	0.44	0.00	0.22
Sebocyte, donor1	11220-116B5	12.60	0.55	4.38	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	11.49	0.00	0.92	0.00	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	8.86	1.03	2.27	0.00	0.41	0.21	0.00	0.82
Sertoli Cells, donor1	11255-116F4	21.54	8.28	0.00	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.92	0.35	1.58	0.00	0.18	0.00	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.00	7.95	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	0.00	2.51	0.00	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.11	1.41	2.04	0.00	0.79	0.00	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	10.26	1.04	1.93	0.00	0.15	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	10.47	1.39	3.85	0.00	0.92	0.31	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.83	1.13	2.77	0.00	0.50	0.13	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.26	1.00	2.28	0.14	0.00	0.14	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.81	0.79	2.98	0.50	0.69	0.10	0.00	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	8.51	0.08	4.04	0.00	0.42	0.08	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	4.34	1.45	2.17	0.00	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.19	0.14	0.55	0.00	0.14	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	29.55	5.37	8.06	0.00	8.06	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.37	0.29	2.16	0.72	0.43	0.14	0.43	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	154.58	1.64	28.63	4.91	0.82	0.82	4.09	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.79	0.13	1.56	0.13	0.13	0.26	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	16.96	0.28	4.17	0.00	0.00	0.70	0.97	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	10.97	0.14	3.94	0.56	0.00	0.14	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	71.47	2.11	25.80	4.86	0.63	2.11	2.33	5.71
Small Airway Epithelial Cells, donor3	11406-118E2	15.07	0.15	2.32	0.07	0.07	0.45	0.15	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	0.31	1.23	0.62	0.62	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.90	2.45	6.45	0.44	2.45	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	0.59	3.53	4.11	1.18	0.59	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.05	9.94	0.88	4.86	6.19	2.43	4.64	4.42
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.66	3.15	3.94	1.18	3.15	0.79	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	2.32	3.09	2.32	0.00	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	0.00	2.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.71	2.26	2.40	5.19	1.73	0.27	3.33	2.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.96	2.44	4.43	0.44	1.33	0.66	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.34	3.84	3.58	3.33	1.66	0.51	1.66	1.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	6.84	0.65	3.91	0.33	0.98	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	2.36	2.66	0.30	1.77	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	7.12	1.28	0.00	4.27	0.71	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.37	1.63	1.14	0.16	0.81	0.33	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	1.22	0.61	0.00	0.61	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.41	1.77	1.77	0.00	3.54	0.25	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	6.12	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	6.20	2.86	6.20	3.34	0.00	1.91	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.04	0.88	1.47	0.00	2.21	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.34	1.72	1.29	0.00	1.08	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.08	1.36	1.57	0.00	1.26	0.42	0.21	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.66	3.09	2.17	0.77	1.86	0.62	1.39	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	0.00	1.08	0.00	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.56	2.09	2.69	2.69	1.79	0.30	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	1.71	2.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	26.94	0.47	1.18	0.00	0.71	0.08	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.76	1.21	2.21	0.30	0.81	0.00	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.63	15.93	3.41	12.52	9.10	2.28	7.28	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	4.83	3.62	4.23	6.64	0.00	1.81	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5.30	1.59	1.59	0.00	2.12	0.79	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.92	1.73	2.13	0.00	2.26	0.13	0.13	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.16	0.50	1.00	0.13	1.25	0.38	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.92	0.76	5.33	0.00	0.51	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.25	5.73	3.17	1.81	4.37	1.81	2.86	5.13
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	3.75	0.00	0.75	4.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	6.46	3.88	3.88	2.58	1.29	1.29	9.05
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.63	1.86	0.93	1.40	4.65	0.47	0.47	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	5.55	3.03	10.60	1.01	0.50	3.03	6.06
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.80	7.21	3.76	10.03	4.39	1.57	3.76	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.72	1.18	0.88	0.00	1.47	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.00	0.92	3.17	0.00	1.00	0.08	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	0.47	1.87	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.92	4.17	4.46	8.06	2.73	1.15	4.17	3.17
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.94	2.29	2.04	5.35	1.78	0.00	0.76	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.83	2.07	1.13	0.75	1.88	0.19	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6.99	0.56	0.42	0.14	0.84	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.47	2.35	0.84	0.59	2.18	0.25	0.42	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.00	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.56	3.43	4.40	8.81	4.40	1.47	3.43	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.49	5.74	1.10	0.66	5.97	0.00	1.10	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.73	1.17	1.46	0.00	1.17	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	30.32	0.19	2.92	0.00	0.19	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.26	1.32	0.79	0.00	0.26	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	39.43	1.12	4.46	0.00	1.86	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.64	1.08	2.52	0.36	1.08	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.05	0.57	1.70	0.00	1.70	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.85	0.39	3.15	0.00	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	22.60	1.27	2.29	0.25	0.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	24.76	0.80	1.20	0.00	2.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	0.84	0.42	0.00	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	0.00	1.83	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	22.05	1.68	4.71	1.85	1.01	0.50	0.67	0.84
Synoviocyte, donor2	11368-117I9	37.04	3.35	3.18	0.17	1.84	0.00	0.34	0.00
Synoviocyte, donor3	11440-118H9	23.01	2.90	2.46	0.22	2.23	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	7.50	0.36	3.22	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.40	0.00	2.32	0.00	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	11.97	0.36	3.44	0.14	0.00	0.14	0.50	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	0.00	3.48	0.39	0.00	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	0.57	3.44	0.00	0.00	0.00	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	36.05	23.74	26.45	1.72	12.06	7.87	2.83	7.63
Urethra, donor2	10319-105A4	34.17	5.40	26.98	0.00	0.00	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.36	0.27	1.59	0.53	0.53	0.53	0.80	0.00
Urothelial Cells, donor2	11600-120H7	10.82	1.20	4.01	0.40	0.40	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	11.23	0.46	2.52	0.00	0.00	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	19.84	0.89	7.80	0.45	0.67	0.00	0.67	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	226.00	109.44	14.24	0.00	72.96	47.16	4.45	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	221.59	91.50	20.01	1.43	85.78	35.74	5.72	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	196.46	50.65	13.69	0.68	36.28	45.18	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	166.32	49.58	9.64	1.72	39.94	38.91	3.10	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	184.19	38.93	11.04	0.58	41.25	32.54	2.32	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	249.90	77.05	16.66	1.04	82.26	40.61	5.21	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	218.43	66.08	24.78	3.67	70.67	32.12	5.51	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	186.23	59.34	10.95	0.00	52.95	45.64	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	7.28	0.62	2.84	0.00	0.99	0.49	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	2.64	0.88	7.04	0.00	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.54	0.56	3.91	0.84	0.00	0.00	0.56	1.40
achilles tendon, donor2	10292-104G4	31.00	24.80	26.86	2.07	4.13	6.20	12.40	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4.84	8.41	1.27	9.43	4.84	7.14	3.31	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	5.57	0.00	0.46	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	16.86	1.90	0.36	0.00	1.31	0.12	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.34	1.90	0.27	0.00	1.09	0.27	0.00	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.12	35.14	0.28	0.00	16.87	14.90	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.51	29.82	1.48	0.21	29.40	9.09	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.89	4.36	1.09	1.09	4.36	3.27	5.99	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	14.54	3.97	4.41	0.00	1.76	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	8.58	1.63	0.00	13.07	2.86	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.52	2.33	2.33	0.00	2.33	0.78	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.62	6.07	0.18	0.00	3.86	2.76	0.74	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	7.80	0.00	0.00	27.30	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.30	6.27	0.70	0.23	9.99	4.88	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	9.06	16.31	1.04	0.00	13.20	9.58	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	12.86	9.64	1.17	0.29	7.60	6.72	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	15.80	3.25	1.86	0.00	2.32	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	3.29	2.88	0.00	7.40	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.23	1.84	1.53	0.00	1.84	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.40	0.85	2.13	0.00	1.28	1.28	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.01	0.61	3.34	0.00	3.34	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.59	1.44	1.93	0.00	1.44	0.48	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.46	4.68	0.67	0.00	3.56	0.22	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	5.34	10.01	3.34	0.00	5.67	3.00	2.33	8.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	9.29	5.57	0.00	5.57	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	5.65	9.79	2.26	0.38	7.16	1.88	1.13	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3.93	2.62	3.05	0.00	1.74	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	15.00	1.87	0.00	5.62	9.37	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	5.18	2.12	3.77	0.00	1.88	0.71	0.71	0.94
adipose tissue, adult, pool1	10010-101C1	55.38	11.94	15.36	0.16	6.83	6.36	2.64	2.48
adipose, donor1	10184-103D4	9.97	0.00	5.28	0.00	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	1.62	0.41	4.87	0.00	0.00	0.41	0.00	0.00
adipose, donor3	10186-103D6	1.91	0.00	2.18	0.00	0.82	0.27	0.00	0.54
adipose, donor4	10187-103D7	0.87	1.73	0.87	0.00	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.26	3.47	1.89	0.00	1.10	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	10.91	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1.60	18.41	0.67	5.47	13.07	11.47	7.34	21.08
alveolar cell carcinoma cell line:SW 1573	10708-109H6	9.29	4.64	3.57	0.36	2.86	4.29	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	32.00	7.65	17.85	1.16	5.56	7.19	0.00	0.93
amniotic membrane cells, donor2	12236-129G4	13.86	1.35	7.78	0.00	1.35	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	36.53	3.54	5.60	0.00	2.65	3.54	0.00	0.29
amygdala - adult, donor10196	10167-103B5	28.46	8.30	9.49	0.00	4.74	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	38.93	4.66	8.92	0.20	4.06	0.81	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	19.04	1.94	6.46	0.32	1.29	1.61	1.61	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	24.83	7.64	3.18	0.13	8.91	2.55	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5.29	9.27	0.88	0.88	8.82	1.99	1.10	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.35	0.67	0.00	0.00	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	37.07	10.00	9.41	0.59	5.30	2.16	0.20	0.00
appendix, adult	10189-103D9	45.80	23.29	12.81	3.49	15.91	5.43	0.78	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.69	1.38	9.97	0.00	2.41	1.03	0.00	0.00
artery, adult	10190-103E1	19.02	6.79	43.48	0.00	1.36	4.08	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	16.08	4.20	7.39	0.87	3.91	5.22	0.43	4.20
b cell line:RPMI1788	10427-106D4	3.72	13.53	1.04	19.93	8.92	7.88	6.99	10.41
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.59	5.55	18.59	2.50	1.66	0.83	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	5.95	5.56	2.98	0.10	3.67	7.64	1.09	3.57
bile duct carcinoma cell line:TFK-1	10496-107C1	15.06	0.84	2.18	0.00	2.01	5.52	0.33	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	2.80	2.80	0.00	6.15	3.36	0.00	0.00
bladder, adult, pool1	10011-101C2	53.89	6.74	6.30	0.00	5.32	0.98	0.87	1.20
blood, adult, pool1	10053-101G8	59.79	28.79	6.64	0.00	13.29	17.72	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	11.99	7.71	0.00	5.14	0.86	0.00	0.00
bone marrow, adult	10192-103E3	56.01	6.07	10.12	0.67	4.72	2.70	0.00	6.07
brain, adult, donor1	10084-102B3	12.30	0.00	5.13	0.00	2.05	4.10	0.00	0.00
brain, adult, pool1	10012-101C3	12.14	1.78	2.90	0.22	1.22	1.45	0.11	0.22
brain, fetal, pool1	10085-102B4	29.39	0.00	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	8.92	0.00	6.94	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	14.60	0.25	6.49	0.00	0.50	0.37	0.00	0.00
breast, adult, donor1	10080-102A8	41.04	11.36	15.15	0.63	7.58	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.72	0.00	1.02	0.00	0.00	0.00	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	10.51	4.95	5.88	0.31	3.71	5.88	0.31	3.40
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.45	6.45	6.45	0.00	3.68	3.45	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.23	0.24	1.94	0.00	1.94	1.94	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	6.11	0.00	3.76	0.00	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	6.78	0.55	7.11	0.00	0.55	0.22	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	0.95	0.32	0.00	0.32	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.52	0.27	1.33	0.00	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	47.20	6.91	6.91	0.00	3.45	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.05	5.69	6.02	0.17	3.18	0.67	0.33	0.67
caudate nucleus, adult, donor10258	10379-105H1	42.79	1.53	6.88	0.00	1.53	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	36.99	2.56	7.69	0.00	1.83	0.00	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	87.40	0.00	46.61	0.00	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	84.98	5.34	44.62	0.00	1.92	0.85	0.00	0.43
cerebellum, adult, pool1	10083-102B2	25.53	0.69	14.83	0.00	0.00	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	124.54	0.00	120.39	0.00	0.83	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	11.35	5.04	5.55	0.00	0.76	0.50	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	11.69	3.65	24.12	21.20	4.39	1.46	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	8.34	0.29	4.03	0.00	0.00	0.43	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	14.91	0.00	2.82	0.00	0.17	0.00	0.17	0.17
cervix, adult, pool1	10013-101C4	54.59	6.51	11.34	0.00	5.04	2.31	0.73	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.68	6.55	3.20	0.42	6.13	3.90	0.70	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	0.00	1.31	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	4.47	0.12	8.45	0.00	0.50	1.62	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	3.94	0.12	0.62	0.00	0.00	0.49	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	4.98	0.00	0.71	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	32.77	3.99	22.79	6.55	2.85	9.97	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	11.73	1.59	9.05	0.20	2.88	0.99	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	34.07	7.69	25.28	8.79	4.40	13.74	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	14.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.64	4.61	1.34	0.38	3.27	0.19	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	3.59	5.28	0.42	0.00	6.97	5.70	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.03	9.24	0.00	0.00	5.65	8.73	0.00	2.31
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.66	10.64	0.24	0.00	6.05	5.56	0.24	3.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.41	10.38	0.81	0.00	7.74	5.70	0.41	3.87
chronic myelogenous leukemia cell line:K562	10454-106G4	1.47	23.26	2.06	0.00	13.25	9.72	0.29	9.42
chronic myelogenous leukemia cell line:KU812	10409-106B4	3.39	4.69	0.78	0.00	4.43	3.65	0.78	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.12	29.03	5.26	0.23	13.26	5.49	0.46	3.43
clear cell carcinoma cell line:TEN	10636-108I6	11.45	6.77	5.21	9.37	5.55	7.11	2.95	3.99
colon carcinoma cell line:CACO-2	10513-107D9	3.48	0.37	7.69	0.00	0.37	1.83	0.00	3.11
colon carcinoma cell line:COLO-320	10420-106C6	10.26	0.38	5.32	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	41.65	7.14	11.90	0.00	2.38	1.19	2.38	0.00
colon, adult, pool1	10014-101C5	34.08	7.64	24.56	0.00	5.52	1.76	0.35	1.88
colon, fetal, donor1	10070-101I7	28.43	3.71	24.72	0.62	7.42	2.47	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	18.33	55.00	9.17	0.00	41.25	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.30	44.19	1.70	2.97	32.72	11.05	1.70	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.13	26.26	0.75	3.32	24.30	11.32	0.15	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	11.70	27.36	0.99	3.95	24.11	13.82	0.85	0.14
corpus callosum, adult, pool1	10042-101F6	35.27	5.75	10.17	0.00	3.76	1.44	0.11	0.44
cruciate ligament, donor2	10295-104G7	34.85	13.78	30.80	19.45	5.67	6.48	4.86	3.24
diaphragm, fetal, donor1	10069-101I6	32.10	0.80	22.47	0.00	4.82	3.21	1.61	0.00
diencephalon, adult	10193-103E4	17.76	1.92	2.40	0.00	1.20	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.43	1.15	0.69	0.00	2.30	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.98	0.00	4.62	0.00	0.00	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.74	4.57	5.06	0.72	1.93	2.89	4.33	9.63
ductus deferens, adult	10196-103E7	72.26	2.99	21.43	0.00	1.00	1.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	4.32	15.84	0.00	1.44	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	3.68	31.63	0.00	3.68	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	57.23	14.04	19.00	0.50	8.84	3.96	0.74	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.33	1.33	6.44	0.22	0.67	2.00	0.00	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	5.02	0.43	7.16	0.00	0.14	0.43	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	3.70	1.85	4.32	0.00	1.85	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.90	9.08	1.21	0.00	4.24	3.03	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.64	3.40	1.54	0.00	2.16	0.62	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	3.94	2.63	0.00	2.63	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	5.03	2.35	6.37	1.01	2.01	3.02	1.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.82	5.26	1.81	0.54	1.81	0.54	0.00	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	11.10	0.48	1.77	0.00	0.32	0.80	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	4.56	0.11	2.89	0.44	0.78	0.44	1.00	1.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.15	0.22	1.65	0.88	0.22	0.55	0.11	0.99
epididymis, adult	10197-103E8	44.58	6.07	22.19	0.42	3.77	6.28	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.87	18.63	21.29	11.89	12.24	8.16	6.74	9.76
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	1.18	2.75	0.79	0.79	1.57	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.32	0.66	3.15	0.00	0.13	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	5.71	0.89	3.64	0.00	0.30	0.10	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.48	0.56	1.68	0.00	0.34	0.45	0.00	0.00
esophagus, adult, pool1	10015-101C6	40.56	4.25	7.96	0.42	2.97	1.38	0.64	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	24.42	0.88	7.14	0.00	0.13	0.13	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	48.29	19.32	53.12	2.41	4.83	14.49	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	58.92	4.21	0.00	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	13.39	5.95	53.58	0.00	2.98	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	6.88	29.81	2.29	3.44	3.44	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	7.29	5.83	10.20	2.91	0.00	5.83	0.00
eye, fetal, donor1	10054-101G9	27.46	2.03	6.10	0.00	2.80	0.51	1.78	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	6.03	0.00	0.00	0.38	0.00	0.00	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	8.78	0.47	3.09	0.00	0.47	0.24	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	16.79	3.19	6.57	0.09	2.16	1.03	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.91	0.00	3.90	0.30	0.60	0.90	1.50	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	5.85	3.66	4.48	1.19	6.13	7.31	2.19	1.92
gall bladder, adult	10198-103E9	35.97	6.76	9.66	0.00	5.79	3.14	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	71.40	74.09	3.22	1.61	68.72	7.52	0.00	2.68
gamma delta positive T cells, donor2	11938-126A3	67.23	54.90	7.47	1.49	52.29	5.98	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.25	0.42	4.44	0.00	1.06	0.63	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.21	1.35	5.03	0.00	0.77	1.55	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	9.18	1.15	6.89	0.00	0.33	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	13.73	0.00	3.66	0.00	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	6.40	0.00	24.67	0.00	0.46	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	6.31	1.03	2.64	0.11	1.15	1.84	0.69	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	9.52	4.90	11.06	0.00	5.18	2.38	0.14	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	15.71	0.25	4.74	0.00	0.25	0.50	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.71	4.33	4.12	0.00	3.80	0.63	1.37	1.79
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.02	4.07	4.35	0.28	3.37	0.70	0.42	1.26
glioblastoma cell line:T98G	10485-107A8	2.87	0.11	2.87	0.00	0.33	0.11	0.00	0.22
glioma cell line:GI-1	10413-106B8	6.44	0.00	3.51	0.00	0.29	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	30.61	5.83	5.10	0.73	3.64	2.19	0.73	2.19
globus pallidus, adult, donor10252	10161-103A8	43.45	9.52	9.03	0.00	2.93	3.42	0.24	0.49
globus pallidus, adult, donor10258	10367-105F7	41.08	5.48	20.54	0.00	2.74	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	26.65	3.20	10.13	0.00	1.60	2.13	0.53	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	44.05	22.02	17.13	0.00	22.02	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.24	3.52	3.20	0.32	2.88	0.64	0.96	1.28
hIPS +CCl2, biol_rep1	14383-156B9	4.59	0.46	0.00	0.00	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.03	0.46	0.91	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.86	1.29	1.29	0.00	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.12	0.00	0.69	0.00	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	17.66	1.10	6.62	0.00	0.00	1.10	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	5.75	24.14	1.15	2.01	21.26	2.30	0.00	1.44
heart - mitral valve, adult	10205-103F7	46.64	15.55	49.63	0.90	13.15	7.77	1.49	5.68
heart - pulmonic valve, adult	10206-103F8	52.03	9.41	40.01	0.00	6.01	12.29	1.05	1.31
heart - tricuspid valve, adult	10207-103F9	76.60	42.46	18.32	5.83	17.49	5.00	14.15	9.99
heart, adult, diseased post-infarction, donor1	10050-101G5	23.47	8.16	27.96	0.00	5.71	9.18	0.41	1.43
heart, adult, diseased, donor1	10051-101G6	38.75	19.59	71.97	0.43	8.09	14.05	2.13	2.98
heart, adult, pool1	10016-101C7	30.36	12.42	28.29	0.00	8.51	8.74	0.92	2.07
heart, fetal, pool1	10046-101G1	60.68	17.97	57.19	0.21	18.79	13.04	2.16	4.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.36	7.71	6.17	0.31	7.71	0.31	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	0.00	16.65	0.00	1.19	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	4.09	0.77	21.33	0.11	1.33	2.32	0.11	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	3.88	1.70	19.78	0.00	1.09	2.67	0.61	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	4.75	0.81	24.66	0.00	0.51	1.82	0.20	1.11
hepatoma cell line:Li-7	10484-107A7	6.12	0.78	8.67	0.00	0.78	0.11	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1.61	2.11	0.80	0.20	1.91	2.61	0.10	0.50
hippocampus - adult, donor10196	10169-103B7	49.21	5.68	8.52	0.00	3.79	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	44.09	5.92	7.14	0.20	3.27	1.02	0.20	1.02
hippocampus, adult, donor10258	10374-105G5	23.40	0.50	7.47	0.00	0.50	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	31.02	1.41	5.64	0.35	0.35	0.35	1.06	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	13.43	0.00	1.22	0.00	0.00	1.22	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.71	0.39	0.20	0.00	0.59	0.79	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.35	0.51	0.25	0.00	0.51	0.76	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.95	0.00	2.26	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	2.84	0.00	1.55	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	0.00	2.28	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.80	0.00	3.50	0.00	0.29	0.29	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.31	0.22	4.31	0.00	0.65	0.43	0.00	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1.25	0.00	3.34	0.00	0.83	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	3.55	0.71	3.55	0.00	0.71	0.47	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	3.54	0.32	1.77	0.00	0.16	0.64	0.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	3.37	0.00	2.02	0.00	0.00	2.69	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.38	0.47	0.47	0.00	0.16	0.94	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.46	0.49	0.98	0.00	0.49	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	0.00	0.00	0.00	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.35	0.00	3.82	0.00	0.19	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	4.36	0.44	3.05	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	0.00	3.50	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	3.96	0.19	4.52	0.00	0.38	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.82	0.45	5.91	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	0.63	4.70	0.00	0.63	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.23	0.16	3.59	0.00	0.33	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	3.19	0.29	4.06	0.29	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.78	0.00	4.18	0.00	0.60	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	2.77	1.66	0.18	0.00	0.92	1.11	0.00	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1.71	0.29	0.29	0.00	0.86	0.29	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	4.49	0.41	0.00	0.00	2.45	1.22	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.11	0.00	2.46	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	2.53	0.63	1.90	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.03	0.00	1.82	0.00	0.00	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1.55	0.52	4.65	0.00	0.52	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	0.00	5.31	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	2.57	0.26	2.05	0.00	0.00	1.03	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	2.05	0.26	1.02	0.26	0.26	0.51	0.26	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	5.30	0.00	3.79	0.00	0.00	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	3.70	0.34	2.02	0.34	1.01	0.34	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	5.31	0.24	0.48	0.00	0.97	0.48	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.79	0.45	0.89	0.00	2.67	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.39	1.46	0.00	0.00	1.46	1.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.58	0.00	2.14	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	0.00	13.01	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.60	0.00	5.30	0.00	0.66	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.64	0.00	2.19	0.00	0.00	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	2.53	0.36	4.34	0.00	0.00	1.09	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.91	0.00	4.63	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	0.00	1.19	0.00	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	3.25	0.95	1.90	0.14	0.68	0.68	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	2.96	0.27	1.89	0.54	0.54	0.00	0.27	0.00
immature langerhans cells, donor1	11904-125F5	22.52	56.66	11.87	134.88	30.03	41.89	64.90	12.59
immature langerhans cells, donor2	11905-125F6	42.78	38.81	7.13	55.45	19.80	30.10	36.44	5.54
insula, adult, pool1	10039-101F3	21.86	2.56	7.38	0.09	2.27	0.95	0.09	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	7.80	0.00	0.98	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	30.04	11.11	16.52	0.50	6.51	7.11	0.60	1.70
kidney, fetal, pool1	10045-101F9	31.83	6.79	19.52	1.63	3.82	2.76	0.21	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.93	4.83	10.23	0.14	5.11	2.56	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.97	4.01	3.87	0.00	3.18	4.84	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.50	0.55	1.83	0.00	0.00	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	15.26	5.45	17.44	0.54	3.27	4.36	1.09	0.00
left ventricle, adult, donor1	10078-102A6	25.79	9.61	27.31	0.00	3.54	8.09	1.01	3.54
leiomyoblastoma cell line:G-402	10721-110A1	1.92	3.83	7.93	0.00	2.46	1.37	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	12.93	3.95	3.23	0.00	3.59	1.80	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	6.52	3.26	0.54	0.54	3.80	0.54	0.54	1.09
leiomyoma cell line:15425	10571-108B4	14.33	2.19	3.40	0.24	2.67	0.49	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	3.14	3.14	2.09	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1.77	4.37	0.83	0.83	4.37	5.43	6.97	11.45
liposarcoma cell line:KMLS-1	10782-110G8	13.43	1.25	3.59	0.00	0.78	0.47	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	3.53	3.05	0.61	0.00	0.85	0.37	0.00	0.12
liver, adult, pool1	10018-101C9	14.91	2.59	16.69	0.49	2.27	0.97	0.32	0.49
liver, fetal, pool1	10086-102B5	6.58	1.88	15.99	0.94	0.94	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.08	4.37	5.25	0.29	2.92	0.87	1.31	1.60
locus coeruleus, adult, donor10252	10165-103B3	28.24	5.54	5.72	0.55	2.77	0.92	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	14.11	1.13	3.39	0.00	1.69	0.56	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	37.44	4.21	11.78	0.84	3.79	4.21	3.36	7.99
lung adenocarcinoma cell line:A549	10499-107C4	7.89	2.77	3.60	0.00	2.91	1.80	0.14	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	0.69	6.20	0.00	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	18.85	11.47	13.71	0.13	8.57	11.73	0.79	6.59
lung, adult, pool1	10019-101D1	43.00	36.38	17.13	3.07	16.07	8.98	3.66	12.05
lung, fetal, donor1	10068-101I5	131.57	27.40	33.96	3.71	18.55	9.13	7.71	16.27
lung, right lower lobe, adult, donor1	10075-102A3	47.65	25.20	15.58	0.46	17.41	8.25	2.75	5.50
lymph node, adult, donor1	10077-102A5	24.61	15.15	4.26	5.68	15.15	4.73	1.89	8.52
lymphangiectasia cell line:DS-1	10727-110A7	1.10	25.86	0.22	2.41	17.10	6.14	0.66	7.23
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7.24	17.81	1.21	5.13	10.72	15.09	1.51	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	0.00	14.44	0.00	0.00	0.00	0.85	5.10
mature adipocyte, donor1	12231-129F8	73.70	12.88	36.85	7.99	8.88	3.55	0.89	1.33
mature adipocyte, donor2	12232-129F9	76.16	17.85	29.88	11.00	7.06	4.77	2.28	1.25
mature adipocyte, donor3	12233-129G1	104.78	23.23	37.69	9.72	9.25	3.32	2.37	2.37
mature adipocyte, donor4	12234-129G2	105.02	15.53	34.48	6.05	8.42	3.42	1.58	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.25	0.00	10.72	0.00	0.00	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	7.90	4.51	5.64	0.00	2.26	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	24.28	5.33	3.86	0.00	1.29	0.74	0.00	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	9.85	0.32	1.59	0.00	0.64	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	43.08	3.84	6.40	0.00	0.43	0.43	2.13	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	19.58	3.04	4.56	0.34	1.69	1.01	0.34	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	35.02	7.00	6.79	0.21	2.33	1.06	0.21	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.79	0.72	6.82	0.00	0.72	1.08	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	25.96	7.14	5.19	0.00	5.19	1.30	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	32.35	10.53	8.67	0.15	2.63	1.39	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	24.65	6.20	9.96	0.65	2.86	1.39	0.41	0.73
medulla oblongata, newborn, donor10223	10361-105F1	21.53	2.08	12.50	0.35	1.39	1.04	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	52.47	5.98	13.95	0.00	4.21	14.39	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	1.96	0.00	0.37	0.00	0.00	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	14.37	0.43	3.31	0.00	0.43	0.29	0.00	0.00
melanoma cell line:G-361	10465-106H6	9.50	0.27	1.36	0.00	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	4.88	27.50	1.99	0.72	17.19	12.30	3.44	19.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	0.00	0.88	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	18.40	0.00	2.59	0.00	0.00	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	10.59	0.61	1.38	0.00	0.61	0.00	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	6.73	0.36	0.91	0.00	0.36	0.00	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	2.07	1.66	0.00	1.66	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.98	0.14	1.55	0.14	0.14	0.14	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.37	0.96	1.54	0.00	0.77	0.19	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	37.48	2.08	0.69	0.00	1.39	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.36	2.06	4.46	0.69	1.03	0.17	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.40	3.11	1.04	0.00	2.07	0.00	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.88	1.72	1.86	1.46	1.59	0.00	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.85	2.97	2.57	2.84	0.95	0.27	1.62	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.95	6.97	1.42	3.70	3.27	1.42	1.42	1.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.05	0.33	6.59	1.32	0.33	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.69	5.26	0.42	0.83	2.91	0.00	0.28	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.27	4.19	0.70	0.35	5.24	0.00	0.70	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.25	11.23	1.63	1.22	7.15	1.02	1.02	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	5.75	0.72	2.16	3.95	1.44	0.72	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.21	4.03	0.72	0.31	3.52	0.00	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.45	8.21	1.60	0.46	4.56	0.91	1.60	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.07	11.75	3.36	0.84	6.29	0.84	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.79	6.13	2.54	1.64	3.14	0.15	0.90	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.24	7.44	0.53	0.88	4.03	0.35	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	27.24	3.68	2.58	0.37	2.95	0.37	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.74	10.30	3.72	3.15	4.86	1.72	1.43	2.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.95	1.68	12.21	0.00	0.42	3.79	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	0.00	3.65	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.91	0.00	1.79	0.00	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.95	0.00	2.36	0.00	0.00	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.93	0.00	3.08	0.00	0.31	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.59	0.24	2.12	0.00	0.00	0.00	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.46	0.00	2.71	0.00	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	0.00	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.63	0.46	4.17	0.00	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.83	0.58	1.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.59	0.45	2.45	0.00	0.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.45	0.24	1.44	0.00	0.24	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	0.00	1.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.42	0.34	3.69	0.00	0.00	0.00	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	0.41	2.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	1.29	2.15	0.00	0.43	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.67	0.97	2.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	0.00	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	0.00	1.60	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	0.82	3.27	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	0.00	2.72	0.00	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	0.00	1.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	0.59	1.78	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	0.00	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	0.63	1.90	0.00	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.21	0.69	3.79	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	6.45	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.11	0.81	1.22	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	0.00	3.18	0.00	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.74	1.77	1.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.51	0.62	4.36	0.00	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	2.67	1.34	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	33.11	1.18	3.55	0.00	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.22	1.38	4.82	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.64	0.49	3.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	0.00	11.22	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	1.27	5.72	0.00	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	35.06	0.40	7.66	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	4.36	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	0.00	5.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.67	0.00	12.74	0.00	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.94	0.82	6.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.68	0.20	7.74	0.00	0.20	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.87	0.97	5.52	0.00	0.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	1.02	5.09	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	1.55	6.96	0.00	1.55	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.66	9.45	12.05	0.71	10.87	4.72	3.54	11.10
mesothelioma cell line:ACC-MESO-4	10494-107B8	5.79	8.80	0.93	1.62	11.58	1.16	4.40	17.84
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	12.82	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.11	12.64	3.49	1.03	6.58	3.70	3.90	12.43
mesothelioma cell line:Mero-25	10850-111F4	5.45	3.18	2.50	1.36	2.04	2.95	2.04	4.99
mesothelioma cell line:Mero-41	10851-111F5	10.76	3.42	1.71	0.24	3.91	0.98	0.49	2.20
mesothelioma cell line:Mero-48a	10852-111F6	5.76	4.43	1.33	1.33	2.44	0.66	0.66	3.32
mesothelioma cell line:Mero-82	10853-111F7	7.62	8.94	3.15	0.79	7.88	6.31	1.05	7.10
mesothelioma cell line:Mero-83	10854-111F8	3.74	6.30	3.92	0.51	3.06	1.70	1.19	2.55
mesothelioma cell line:Mero-84	10855-111F9	6.82	12.89	0.25	0.25	8.34	0.51	1.01	1.01
mesothelioma cell line:Mero-95	10856-111G1	9.52	2.48	1.45	0.00	2.90	0.62	0.00	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	6.46	5.14	3.15	5.47	2.48	0.66	3.98	13.58
mesothelioma cell line:NCI-H226	10846-111E9	1.45	5.43	0.18	1.63	2.90	2.35	1.81	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	2.90	3.42	1.54	0.51	2.22	1.54	2.05	5.30
mesothelioma cell line:NCI-H28	10845-111E8	11.96	2.04	9.67	0.00	0.76	1.53	0.25	0.25
mesothelioma cell line:No36	10857-111G2	6.20	0.65	6.52	0.33	1.63	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	14.90	2.98	3.52	0.00	1.90	0.00	0.27	1.08
migratory langerhans cells, donor1	11901-125F2	25.53	63.33	4.99	20.54	32.05	16.51	3.07	2.30
migratory langerhans cells, donor2	11902-125F3	19.42	39.20	2.69	20.03	22.35	14.65	1.71	2.08
migratory langerhans cells, donor3	11903-125F4	14.54	42.72	4.49	41.28	20.64	25.67	3.23	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.57	0.33	4.24	0.00	0.00	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	4.24	0.85	1.27	0.00	0.42	0.21	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.53	5.30	3.92	0.23	6.45	13.13	1.15	3.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.75	17.13	1.14	7.99	17.51	9.70	1.90	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	9.05	11.09	2.22	0.00	11.64	3.14	0.55	0.00
myeloma cell line:PCM6	10474-106I6	2.77	1.58	0.59	0.40	0.79	0.79	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	5.07	5.07	3.04	0.51	2.03	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.85	0.98	1.77	0.00	0.20	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.39	0.78	3.90	0.11	0.00	0.45	0.33	2.79
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.84	0.37	6.18	0.00	0.74	1.40	0.59	3.46
nasal epithelial cells, donor2	12227-129F4	17.11	1.10	5.52	0.55	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	17.96	0.00	12.72	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	15.18	0.63	4.01	0.00	0.00	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	15.09	0.00	6.71	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	61.68	0.24	1.66	0.00	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.73	0.79	2.06	0.00	0.00	0.16	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	6.64	0.60	0.60	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	0.64	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	5.32	0.80	4.52	0.27	1.33	0.53	0.53	0.27
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	44.62	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	212.49	0.00	13.28	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	161.00	0.00	28.41	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	4.90	0.51	2.03	0.00	0.17	0.34	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	0.00	2.40	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.54	0.00	1.60	0.00	0.00	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.50	0.53	4.47	0.00	1.31	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	26.90	2.16	6.19	0.09	2.34	1.12	0.19	0.47
occipital cortex - adult, donor10196	10172-103C1	16.48	6.18	8.24	0.00	2.06	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	37.57	6.98	10.20	0.27	5.37	1.07	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	22.56	2.18	4.73	0.36	1.46	0.36	1.46	1.82
occipital lobe, adult, donor1	10076-102A4	12.60	2.62	3.41	0.52	0.79	0.79	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	28.75	0.43	6.44	0.00	0.00	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	9.70	1.73	4.26	0.00	1.34	1.50	0.16	0.24
olfactory region, adult	10195-103E6	17.96	2.87	4.78	0.00	1.53	1.53	0.38	0.00
optic nerve, donor1	10277-104E7	36.02	4.00	8.00	0.00	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.10	0.00	1.71	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.63	0.14	5.77	0.00	0.00	0.14	0.00	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.84	0.00	1.69	0.00	0.00	0.00	0.17	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.74	0.00	1.50	0.00	0.12	0.12	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	12.64	0.29	3.23	0.00	0.88	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	4.67	4.67	0.00	0.93	4.67	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	3.39	0.21	2.12	0.00	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	27.08	2.88	3.76	0.17	2.53	0.61	0.44	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.23	2.20	0.73	0.92	1.28	1.10	0.18	0.55
pancreas, adult, donor1	10049-101G4	26.34	1.88	9.41	0.00	1.88	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	5.03	0.56	6.15	0.00	0.00	0.56	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	16.01	2.90	8.18	0.17	2.38	1.53	0.51	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.42	15.73	6.62	3.64	15.40	7.12	2.48	1.99
paracentral gyrus, adult, pool1	10035-101E8	15.65	2.29	4.67	0.09	1.19	1.01	0.00	0.37
parietal cortex, adult, donor10258	10373-105G4	20.55	0.73	4.40	0.00	1.47	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	13.17	5.64	6.58	0.00	2.82	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	29.93	4.56	5.70	0.00	1.43	1.71	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	15.33	2.91	4.32	0.09	1.41	0.79	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	27.16	0.97	1.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	25.42	0.75	7.48	1.12	0.00	1.12	1.50	1.87
parotid gland, adult	10199-103F1	35.77	0.62	11.72	0.00	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	51.56	4.83	20.41	0.00	3.22	2.15	2.69	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.45	0.19	0.56	0.00	0.37	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	12.68	0.29	6.26	1.31	0.29	0.29	1.02	0.73
pineal gland - adult, donor10196	10179-103C8	41.28	6.45	6.45	0.00	1.29	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	43.82	7.70	16.58	0.59	5.33	1.78	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	28.85	1.25	14.42	0.00	1.88	3.14	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	50.59	4.05	20.24	0.00	2.02	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	70.36	8.34	30.75	0.00	6.25	2.61	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	31.50	2.55	9.36	0.00	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	27.95	6.13	16.45	0.22	1.61	3.55	2.90	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	6.09	11.92	1.46	3.05	7.15	4.11	1.32	5.56
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.52	5.29	7.78	0.62	4.82	0.78	0.16	1.56
pons, adult, pool1	10033-101E6	20.40	3.61	8.18	0.17	1.46	1.29	0.00	0.60
postcentral gyrus, adult, pool1	10032-101E5	11.59	2.53	5.58	0.09	0.96	1.39	0.00	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	29.28	29.28	0.00	14.64	16.73	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	0.00	16.52	0.00	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.67	15.44	10.34	0.00	11.94	8.45	0.58	0.87
prostate cancer cell line:PC-3	10439-106E7	9.08	0.18	3.81	0.00	0.00	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	38.63	4.08	11.16	0.00	2.54	1.18	0.09	0.27
putamen, adult, donor10196	10176-103C5	61.61	6.14	3.30	0.00	0.94	0.47	1.42	0.94
putamen, adult, donor10252	10152-102I8	52.94	1.96	5.88	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	1.09	4.37	0.00	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	23.19	0.97	2.42	0.00	0.72	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	56.22	2.25	9.75	0.00	3.00	2.25	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	6.40	2.04	5.53	0.00	2.91	2.33	0.00	0.00
rectum, fetal, donor1	10067-101I4	27.82	5.56	27.82	1.39	4.17	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.09	3.82	1.91	0.42	4.24	4.24	1.27	3.82
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.04	24.02	2.49	0.00	10.77	2.90	0.00	0.83
retina, adult, pool1	10030-101E3	36.48	17.89	16.40	0.10	8.55	2.58	0.60	1.29
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	4.55	2.21	4.30	0.00	1.48	2.83	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.94	0.00	8.44	0.00	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	1.52	0.76	0.00	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	26.22	1.46	7.61	0.16	0.32	0.00	0.00	0.97
salivary acinar cells, donor2	11772-123I8	33.73	0.55	5.23	0.00	1.10	0.00	0.14	0.28
salivary acinar cells, donor3	11773-123I9	32.44	0.66	12.58	0.00	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	54.34	5.72	10.87	0.57	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.75	0.93	0.67	0.08	1.26	0.00	0.00	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.58	0.82	0.59	0.24	0.82	0.12	0.00	0.00
seminal vesicle, adult	10201-103F3	54.49	7.94	17.46	0.00	2.65	3.17	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.07	0.49	10.45	0.00	0.97	1.21	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	0.50	3.02	1.51	1.26	0.75	0.50	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	0.00	7.02	0.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.82	0.27	6.72	0.00	0.00	0.27	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	6.30	0.22	3.21	0.00	0.22	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.19	0.90	5.68	0.00	0.65	1.42	1.42	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	52.49	9.22	156.05	0.00	7.09	10.64	4.26	2.84
skeletal muscle, adult, pool1	10023-101D5	33.82	5.76	43.78	0.36	3.12	4.32	1.20	1.68
skeletal muscle, fetal, donor1	10066-101I3	8.04	0.00	7.04	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	6.79	0.00	0.00	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	50.50	3.16	12.62	0.00	0.63	0.00	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.67	0.00	9.01	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	5.04	0.00	1.58	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	12.72	1.16	2.12	0.00	0.39	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	14.01	1.48	8.74	0.00	0.49	1.65	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	3.06	0.16	0.97	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	21.36	2.18	18.52	0.00	1.53	2.83	0.00	0.00
small intestine, adult, pool1	10024-101D6	23.65	8.72	41.21	0.84	6.21	2.87	1.07	2.15
small intestine, fetal, donor1	10064-101I1	21.13	4.91	12.28	0.00	4.18	1.23	1.72	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	5.64	0.00	4.62	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	69.27	4.39	10.34	0.00	3.36	1.29	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	11.26	0.00	4.02	0.00	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	28.22	3.21	5.96	0.46	3.67	0.92	1.84	1.84
spinal cord, adult, donor10252	10159-103A6	31.94	7.49	13.01	0.00	7.10	1.18	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	35.28	2.08	16.60	0.00	2.77	0.00	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	27.44	3.66	8.54	0.00	2.44	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	41.33	2.30	15.61	0.00	3.67	0.46	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.65	2.39	5.68	0.60	1.64	0.00	0.15	0.15
spleen, adult, pool1	10025-101D7	29.52	24.56	9.14	2.42	16.08	7.16	2.20	2.75
spleen, fetal, pool1	10044-101F8	42.27	22.57	14.22	1.75	12.32	5.56	3.18	1.67
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.97	12.32	1.35	12.42	7.14	3.83	9.94	8.80
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.78	0.00	1.90	0.00	0.00	0.00	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.82	5.24	15.38	0.00	2.45	5.94	0.35	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.60	1.95	2.74	0.39	3.13	4.30	1.56	5.47
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.40	0.00	2.25	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.86	0.00	0.85	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.12	0.85	20.31	0.42	4.65	2.12	1.69	0.42
stomach, fetal, donor1	10062-101H8	28.84	7.48	16.02	0.00	3.20	5.34	2.14	1.07
submaxillary gland, adult	10202-103F4	46.71	3.42	12.53	1.14	3.99	1.71	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	40.29	6.23	11.42	0.21	4.98	0.83	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	22.24	1.55	8.28	0.00	2.07	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	28.97	4.24	14.84	0.00	0.00	0.71	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	9.17	0.46	3.21	0.00	0.23	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	12.21	2.03	6.19	0.08	1.36	1.19	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	15.67	0.00	2.85	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.53	0.88	6.15	0.00	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	26.18	1.40	1.75	0.00	1.05	0.00	0.35	0.00
tenocyte, donor2	11765-123I1	33.19	2.29	3.05	0.00	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	18.53	0.37	5.19	0.00	1.85	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.23	0.51	6.12	0.00	0.00	1.53	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	4.62	13.41	1.23	0.00	16.65	6.63	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	1.86	0.00	0.46	0.00	0.00	0.62	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.22	0.63	4.70	0.00	0.63	5.33	0.13	2.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.51	0.38	3.03	0.00	1.13	9.45	0.00	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.34	2.84	5.78	0.00	3.16	11.78	0.00	1.42
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	11.07	0.65	12.05	0.00	0.00	12.05	0.33	0.65
testis, adult, pool1	10026-101D8	19.76	10.42	6.66	0.11	5.91	1.72	0.54	1.93
testis, adult, pool2	10096-102C6	19.40	12.63	8.57	0.00	6.77	1.80	0.45	1.35
thalamus - adult, donor10196	10168-103B6	35.33	3.31	16.56	0.00	3.31	3.31	4.42	2.21
thalamus, adult, donor10252	10154-103A1	41.26	5.00	9.38	0.31	4.53	1.41	0.00	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	4.62	4.62	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.82	1.65	3.95	0.00	0.66	0.82	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	11.51	1.15	9.78	0.00	0.00	0.58	0.58	2.88
throat, adult	10209-103G2	40.45	6.74	23.22	1.00	3.99	5.74	1.75	2.25
throat, fetal, donor1	10061-101H7	26.20	2.74	14.93	0.00	2.13	2.13	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	17.49	0.60	1.79	0.00	0.20	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	38.57	5.37	2.88	0.80	4.47	1.89	0.70	0.60
thymus, fetal, pool1	10043-101F7	64.52	10.08	7.17	1.87	9.14	3.43	2.39	2.29
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.16	1.99	7.84	0.13	2.39	1.86	0.40	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	8.66	13.27	9.92	0.00	7.96	5.73	0.00	0.84
thyroid, adult, pool1	10028-101E1	44.70	12.13	20.62	0.19	9.14	10.45	0.47	2.15
thyroid, fetal, donor1	10060-101H6	24.78	4.22	15.03	0.00	3.69	2.11	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	15.40	61.59	0.00	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	31.63	4.42	20.70	2.56	1.86	2.09	2.79	1.16
tongue, fetal, donor1	10059-101H5	20.10	2.36	13.79	1.97	1.18	1.58	0.00	0.39
tonsil, adult, pool1	10047-101G2	45.08	22.64	8.72	2.80	19.23	5.71	4.11	6.51
trachea, adult, pool1	10029-101E2	43.68	9.65	9.00	1.31	4.17	2.62	2.21	4.42
trachea, fetal, donor1	10058-101H4	36.16	2.69	13.46	0.00	2.31	0.77	1.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.75	2.13	3.54	0.35	0.35	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	5.07	0.10	2.03	0.91	0.41	0.71	0.51	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	9.09	6.42	7.36	0.63	7.52	2.51	0.31	1.57
tridermal teratoma cell line:HGRT	10694-109G1	13.32	1.90	5.71	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	9.57	4.15	7.36	0.00	3.30	3.22	0.00	0.59
umbilical cord, fetal, donor1	10057-101H3	14.61	4.17	25.04	0.00	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	68.42	11.09	13.14	0.17	8.53	2.73	0.68	0.34
uterus, fetal, donor1	10055-101H1	23.55	4.61	5.63	0.00	1.54	0.51	0.00	0.51
vagina, adult	10204-103F6	60.74	11.63	8.40	0.00	6.46	3.23	0.00	1.29
vein, adult	10191-103E2	40.77	10.30	6.80	0.88	8.99	4.60	0.66	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	3.47	9.61	0.00	8.01	2.94	5.61	4.01	5.07